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1.1 Secretory Vesicle Exocytosis 
 Intercellular communication between neurons or neuroendocrine cells is mediated by 
secretory vesicle exocytosis. Neurotransmitters can be released from two types of 
vesicles: Synaptic vesicles (SVs), which typically contain classical neurotransmitters 
such as glutamate or gamma-aminobutyric acid (GABA) and which mediate fast 
synaptic transmission, and large dense-core vesicles (LDCVs), which typically contain 
neuropeptides or monoamines and which usually mediate slower modulatory effects. 
Several characteristic similarities and differences exist between SVs and LDCVs. Both 
types of vesicles require a Ca2+ trigger in order to fuse, and they share many common 
proteins that are involved in the control and execution of their membrane fusion. On the 
other hand, the kinetics of their fusion and its physiological regulation are usually 
different, indicating the existence of distinct molecular mechanisms in SV- and LDCV- 
mediated secretion (Speese et al., 2007; Zhou et al., 2007). In the present study, I 
investigated the role of priming proteins of the Munc13 family in the regulation of 
LDCV-mediated exocytosis. Studies in C. elegans had indicated that the nematode 
Munc13-homlogue Unc-13 specifically regulates SV priming while the CAPS 
homologue Unc-31 mediates the corresponding regulatory effect in LDCV fusion 
(Speese et al. 2007), although Unc-13 may also be required in LDCV exocytosis under 
certain physiological conditions (Zhou et al., 2007). Similarly, a series of earlier studies 
in mammalian systems had led to the conclusion that CAPS proteins are selectively 
responsible only for LDCV-mediated exocytosis (e.g. Tandon et al., 1998; Rupnik et al., 
2000; Sadakata et al., 2004 and 2007; Speese et al., 2007). However, a recent study in 






SV-mediated exocytosis (Jockusch et al., 2007), indicating that a restriction of 
CASPS/Unc-31-dependent regulatory processes to LDCV-mediated secretion may not 
exist in mammals. The present study was conducted in order to complement these data 
by analyzing whether Munc13-function in mammals is specific to SVs, as would be 
indicated by the C. elegans data (Speese et al., 2007; Zhou et al., 2007) or whether they 
play a more general role in the control of both SV and LDCV fusion.  
 
 
1.1.1 SV Exocytosis  
 The exocytosis of SVs is part of a complex trafficking cycle consisting of multiple 
membrane fusion and fission steps and is restricted to so called active zones, where the 
final steps of vesicle fusion are tightly coordinated in space and time (Wojcik and 
Brose, 2007; Figure 1).  
 Transmitters are filled into SVs by dedicated vesicular carriers, whose activity is driven 
by a proton electrochemical gradient that is generated by a vacuolar-type ATPase. 
Transmitter-filled SVs in axon terminals dock to the active zone plasma membrane and 
undergo a biochemical modification called priming. Only these primed and fusion-
competent vesicles are able to fuse with the active zone plasma membrane in response 
to an action potential and the concomitant influx of Ca2+ through voltage-gated Ca2+ 
channels. P/Q- and N-type Ca2+ channels are thought to be the main mediators of action 
potential triggered Ca2+ influx in presynaptic terminals while R- and I-type Ca2+ 
channels play a modulatory role (Dietrich et al., 2003). Ca2+ influx triggers two different 
components of release: A fast component of release (synchronous, phasic) is rapidly 
induced in as little as 50 µs after a Ca2+ stimulus, and a second slow component 
(asynchronous, tonic) often continues for more than 1 s after the action potential 






recycled for reuse. The main recycling pathway involves clathrin-mediated endocytosis. 
Under certain circumstances however, e.g. during phases of high presynaptic activity, 
SVs appear to be also recycled in part by a faster pathway, which is termed kiss-and-
run, and which is thought to involve direct fission of transiently fusing SVs without a 
full collapse of the SV into the presynaptic membrane. Endocytosed SVs are reused and 
refilled with neurotransmitter either directly or after passing through an early endosomal 
compartment (Wojcik and Brose, 2007; Figure 1). 
  
 
Figure 1. The SV Cycle (image from Brose et al., 2000). 
 
 Six large active zone specific proteins - Munc13s, RIMs, Piccolo, Bassoon, ERCs, and 
α-liprins- are involved in the regulation of active zone function. They engage in 
multiple protein-protein interactions with each other and thereby form a complex active 
zone protein network. Munc13s (mammalian Unc-13 proteins) and RIMs (Rab3-
interacting molecules) are multidomain proteins that bind to each other and also interact 
with multiple other presynaptic protein components (Brose et al., 1995; Wang et al., 






the active zone cytomatrix and thought to act as presynaptic scaffold proteins (Cases-
Langhoff et al., 1996; tom Dieck et al., 1998). ERCs (ELKS/Rab3-interacting 
molecule/CAST) are coiled-coil proteins that bind to RIMs and to RIM-binding proteins 
(RIMBPs), which are SH2 (Src homology) domain proteins (Wang et al., 2002; Wang 
et al., 2000). Finally, α-liprins bind to ERCs, RIMs, and several receptor protein 
tyrosine phosphatases (Ko et al., 2003; Schoch et al., 2002; Serra-Pages et al., 1998).  
 
 
1.1.2 LDCV Exocytosis  
 As is the case with SVs, LDCV fusion is triggered by transient rises in the intracellular 
Ca2+ concentration. LDCV fusion has been studied in diverse cell types, including 
pancreatic exocrine, adrenal chromaffin, and hemopoietic cells, as well as platelets, 
neutrophils, and mast cells. It appears to share many characteristics and protein 
components with SV-mediated secretion (Burgoyne and Morgan, 2003; Martin, 1994). 
Like SV fusion, LDCV fusion is triggered by Ca2+, which typically enters secretory 
cells after depolarization through voltage-gated Ca2+ channels, and executed by 
SNAREs, which mediate the membrane merger (Figure 2). In addition, several SNARE 
regulatory proteins such as Munc18 are common to both vesicle systems. On the other 
hand, the biogenesis of LDCVs and their fate after fusion are different from the 
corresponding processes governing SV trafficking. Unlike SVs, LDCVs have to be 
assembled de novo at the Golgi apparatus owing to the fact that they need to contain 
enzymes and secreted peptides/proteins (Kim et al., 2006; Dikeakos and Reudelhuber, 
2007). In addition, although involving SNAREs, their cell biological mechanism of 
fusion (e.g. compound fusion vs. individual vesicle fusion), and their recycling may also 









Figure 2. The SNARE Complex.  
Vesicular and plasma membrane SNARE proteins assemble into the trimeric SNARE complex. Assembly 
of this complex is thought to drive the membrane fusion reaction (top), possible via (stalk-like) 
hemifusion intermediates (bottom). Images are from R. Jahn, Göttingen. 
  
 LDCV secretion has been best characterized in adrenal chromaffin cells. These cells are 
part of the adrenal medulla, which contains three types of chromaffin cells, adranaline- 
(85 %), noradrenaline- (14-15 %), and dopamine-containing cells (<1 %) (Figure 3). All 
three types of hormone are synthesized from tyrosine in the adrenal medulla (Trifaro, 
2002). A single chromaffin cell contains about 30,000 vesicles or chromaffin granules 
(Carmichael and Winkler, 1985), which contain a mixture of hormones and 
neuropeptides.  
 Due to their spherical shape, chromaffin cells are nicely amenable to 
electrophysiological recordings of membrane capacitance, membrane characteristics, 






with patch-clamp recordings of membrane capacitance and amperometric recordings of 
released catecholamines, chromaffin cells can be used to study all aspects of LDCV 
fusion with very high temporal resolution and in highly reliable quantitative terms. This 
extraordinary experimental accessibility together with the fact that they are derived 
from the neural crest, i.e. from the same precursors that give rise to sympathetic 
neurons, have led to the widespread use of chromaffin cells as a model system for the 
analysis of regulated transmitter release.  
 
 
Figure 3. Chromaffin Cells From the Mouse Adrenal Medulla. 
(A) Organs in the mouse abdomen (from http://www3.niaid.nih.gov). 1. Salivary gland, 2. rib cage, 3. 
diaphragm, 4. liver, 5. spleen, 6. pancreas, 7. forestomach, 8. glandular stomach, 9. kidney, 10. ascending 
colon, 11. male urogenital system. (B-C) Adrenal glands lie above both kidneys. (D) Scanning electron 
micrograph of a chromaffin cell (from http://webpages.ull.es). 
 
 The LDCVs of adrenal chromaffin cells can be classified functionally into distinct 
pools. These are distinguished based on their release kinetics, which in turn can be 






depolarizations or Ca2+ release from a previously infused photolabile chelator using 
UV-flash photolysis (Figure 4). Within the first second after flash photolysis of caged 
Ca2+, a readily releasable pool (RRP) of vesicles fuses in an exocytotic burst, which 
consists of a fast and a slow component. The vesicles from the fast burst component of 
flash photolysis experiments correspond to the RRP released in response to a more 
physiological depolarization stimulus and fuse with a time constant of about 20-40 ms. 
Vesicles from the slow burst, which are also referred to as the slowly releasable pool 
(SRP), fuse with a time constant of about 200 ms (Becherer and Rettig, 2006). These 
slow burst vesicles are not released by depolarization, but they represent a precursor 
pool of the fast burst/RRP vesicles (Voets et al., 1999). In addition to these vesicle 
pools, depolarizing stimuli allow the detection of those vesicles situated closest to Ca2+ 
channels as an immediately releasable vesicle pool (IRP) (Schneggenburger and Neher, 
2005). The IRP vesicles are also released during flash photolysis, but due to the global 
increase in intracellular Ca2+ cannot be distinguished as a separate pool. 
 Unlike SVs, the readily releasable pools of LDCVs in adrenal chromaffin cells are not 
concentrated at active zones but rather docked and primed at the entire plasma 
membrane (Allersma et al., 2004; Olofsson et al., 2002; Parsons et al., 1995). 
Exocytotic delay times and release rates are typically slightly longer in LDCVs than in 
SVs (Voets et al., 1999 and 2000). The pool of release ready vesicles is refilled from 
vesicles of the unprimed pool (UPP), which are close to but morphologically detached 
from the plasma membrane by some 200 nm. The sustained component is the final 
phase of the capacitance trace after flash photolysis. It is due to docking and priming of 
vesicles from the UPP and subsequent fusion. Vesicles in the UPP are replenished from 
a depot pool (DP), which represents the largest pool of LDCVs in adrenal chromaffin 
cells. The DP is composed of the vesicles that are more than 200 n away from the 






           
Figure 4. Measuring LDCV Fusion and Exocytosis in Chromaffin Cells. 
By UV-flash photolysis of the photolabile Ca2+ chelator NP-EGTA-Ca2+ in the cell, the intracellular Ca2+ 
concentration can be increased in a step-wise fashion to 15-20 µM (bottom right panel, top trace). Fusion 
of LDCVs can be measured by a patch-clamp electrode as an increase in the cell membrane capacitance 
(bottom right panel, bottom trace). Images are modified from J. Rettig and J. Sørensen, Göttingen. 
 
 
1.1.3 The SNARE Core Complex and SNARE-Regulating Proteins 
 SNAREs (soluble N-ethylmaleimide sensitive factor attachment protein receptors) are 
localized to the various intracellular organelles. They comprise a family of mostly 
membrane-tethered proteins containing a coiled-coil SNARE motif, and they regulate 
fusion reactions and target specificity in vesicle trafficking. Based on their localization, 
SNAREs can be classified into vesicle associated v-SNAREs and target-membrane-
associated t-SNAREs. The SNARE motifs are homologous 70-amino acid sequences 
that can be segregated into four distinct classes, R-, Qa-, Qb-, and Qc-SNARE motifs. 






four helical bundle that drives the fusion of the resident membranes. Fusion of SVs is 
mediated by three SNARE core complex component proteins: Syntaxin and SNAP-25 
(synaptosome-associated protein of 25 kDa) on the presynaptic plasma membrane, and 
Synaptobrevin (also called vesicle-associated membrane protein; VAMP) on the vesicle 
membrane (Söllner et al., 1993). The core of this complex is formed by the R-SNARE 
motif of Synaptobrevin, the Qa-SNARE motif of Syntainx 1, and the Qb- and Qc-motifs 
of SNAP-25. Their association drives the fusion of the SV membrane with the active 
zone plasma membrane (Figure 2). After fusion, the trimeric complex binds to a 
complex of the ATPase N-ethylmaleimide-sensitive factor (NSF) and soluble NSF 
attachment proteins (SNAPs), which disassemble the SNARE complex and make the 
individual components available for subsequent reuse (Hayashi et al., 1995).  
 SNARE complexes are essential for fusion of SVs and LDCVs - genetic ablation of 
synaptic SNAREs in Drosophila, C. elegans, and M. Musculus abolishes evoked 
neurotransmission (Nonet et al., 1998; Schoch et al., 2001; Schulze et al., 1995; 
Washbourne et al., 2002). Several proteins are critically involved in the control of 
SNARE core complex assembly and function. (i) SNARE complex formation is 
controlled by proteins of the Sec1/Munc18-like (SM) family (Jahn et al., 2003). SM 
proteins bind to Syntaxin-like SNAREs. Munc18-1, a key SM protein of mammalian 
that controls synaptic fusion, interacts with a conformation of Syntaxin that is closed 
and prevented from SNARE complex formation. In addition, Munc18 can bind the 
Syntaxin N-terminus. One role of Munc18 in neurotransmitter release from SVs and in 
LDCVs is that of a docking factor that acts prior to SNARE complex assembly. The 
number of membrane-proximal LDCVs is reduced in chromaffin cells of Munc18-1 
deletion mutant mice (Voets et al., 2001). Likewise, docking of SVs at the C. elegans 
neuromuscular junction is impaired in mutants lacking the Munc18-1 orthologue Unc-






mammalian Munc18-1 deficient central synapses, although these synapses do not 
release neurotransmitter (Verhage et al., 2000). (ii) Munc13 and CAPS proteins are 
essential for SV priming (Varoqueaux et al., 2002; Jockusch et al., 2007). Their role 
will be discussed in further detail below. (iii) The function of Munc13s is counteracted 
by Tomosyn, which can act as a scavenger of SNAREs, thus limiting SNARE complex 
assembly (Wojcik and Brose, 2007). (iv) Complexins bind to the assembled SNARE 
complex and maintain it in a highly fusogenic state (Brose, 2008). (v) Synaptotagmins 
act as the Ca2+ sensors of regulated SV and LDCV secretion (Südhof, 2004). 
Synaptotagmins form a large family of proteins (Craxton, 2004), which contain an N-
terminal transmembrane domain, followed by a linker region and two C-terminal C2 
domains that are referred to as C2A and C2B. Synaptotagmin 1 is the family member 
best characterized. Its C2A and C2B domains bind Ca2+ and interact with phospholipid 
membranes in a Ca2+-dependent manner (Bai et al., 2004; Bai and Chapman, 2004; 
Brose et al., 1992). Synaptotagmin 1 likely acts as a Ca2+-sensor and trigger of fusion by 
simultaneously binding in a Ca2+-dependent manner to the assembled SNARE complex 
and the phospholipids of the fusing membranes (Chapman et al., 1995; Kee and 
Scheller, 1996; Li et al., 1995; Rickman et al., 2003; Wojcik and Brose, 2007), at the 
same time displacing Complexin from the complex.  
 
 
1.2 The Mammalian Unc-13 Protein Family  
 Munc13 proteins are homologues of C. elegans Unc-13, which was initially identified 
as the product of a gene whose mutation causes unccordinated movements and reduced 
transmitter release (Brenner, 1974; Hosono and Kamiya, 1991; Brose et al., 1995). 






al., 1995) and a distantly related variant called Munc13-4 (Koch et al., 2000) (Figure 5). 
Munc13-1, -2, and -3 are mainly expressed in neurons. In mice and rats, Munc13 
expression starts around birth and increases to reach plateau at postnatal days 20-30, 
when synapse formation is largely complete. Munc13s 1-3 are localized to presynaptic 
active zones, while Munc13-4 is present mainly in lung and lymphocytes.  
 Munc13s 1-3 have a complex domain structure with divergent N-termini and conserved 
C-terminal regions, which contain a C1 domain that binds diacylglycerol and 
phorbolesters, two C2 domains one of which (C2B) binds Ca2+ (Dai et al., 2005; Guan 
et al., 2008; Lu et al., 2006; Rizo and Rosenmund, 2008), and two Munc13-homology 






Figure 5. Domain Structure of Munc13s and Baiap3.  
Munc13s contain a C1 domain, two or three C2 domains and two Munc13-homology domains (MHDs). 
Baiap3 also contains two C2 domains and two MHDs, but lacks the variable N-terminal region found in 






 Munc13-1 is expressed in almost all neurons of the CNS, Munc13-2 is mainly 
expressed in cortex and hippocampus, and Munc13-3 is mainly found in cerebellum and 
brainstem (Augustin et al., 1999a). One splice variant of Munc13-2, b-Munc13-2, is 
brain specific, while a second one, ubMunc13-2, is also found in other tissues (Betz et 
al., 2001).  
 Loss of Munc13-1 in mutant mice does not affect synapse, neuron, or brain 
morphology but causes an almost complete block (90 %) of SV priming in hippocampal 
glutamatergic neurons and a concomitant almost complete arrest of SV fusion in these 
cells, while GABAergic neurons are not affected by Munc13-1 deletion (Augustin et al., 
1999b). The remaining release in glutamatergic and GABAergic cells of Munc13-1 
deficient mice is due to the presence of Munc13-2 and totally eliminated upon the 
additional deletion of Munc13-2 (Varoqueaux et al., 2002). Similarly, evoked release at 
cholinergic neuromuscular synapses is almost shut down upon deletion of all three 
Munc13 genes in mice (Varoqueaux et al., 2005), as is GABAergic and cholinergic 
transmission at the neuromuscular synapse of unc-13 null-mutant C. elegans (Richmond 
et al., 1999). Loss of the Drosophila homologue Dunc-13 completely abolishes synaptic 
transmission at the fly glutamatergic neuromuscular junction (Aravamudan et al., 1999).  
 Munc13s are thought to mediate vesicle priming by binding to the N-terminus of 
Syntaxin, thereby keeping it in its open conformation which is able to enter SNARE 
complex formation (Betz et al., 1997; Brose et al., 2000; Richmond et al., 2001). 
Munc13s are regulated by diacylglycerol through their C1 domains (Betz et al., 1998; 
Rhee et al., 2002) and by Calmodulin (Junge et al., 2004), and the presynaptic targeting 
of Munc13-1 and ubMunc13-2 is controlled by the interactions of their respective N-
termini with RIM (Betz et al., 2001; Andrews-Zwilling et al., 2006). As mentioned 
above, the MHDs of Munc13s and their flanking sequences are essential for the 






corresponding minimal priming region, called MUN domain, domain binds to 
membrane-anchored SNARE complexes and to Syntaxin 1-SNAP-25 heterodimers 
(Guan et al., 2008).  
 The role of Munc13 proteins in LDCV secretion is less well understood. 
Overexpression of Munc13-1 in mouse chromaffin cells leads to an increase in secretion 
as compared with wild type cells. More specifically, the size of the exocytotic burst is 
increased 3-4 fold, and the sustained component of release is strongly augmented upon 
Munc13-1 overexpression. Importantly, the overexpression of Munc13-1 does not affect 
the rate constants of fusion from releasable pools, indicating that Munc13-1 can drive 
priming of chromaffin secretory granules from a docked to a fusion competent state, 
which is apparently rate limiting in adrenal chromaffin cells (Ashery et al., 2000). This 
gain-of-function effect of Munc13-1 overexpression in chromaffin cells requires the two 
MHDs with the flanking C2C domain and its ability to bind Syntaxin (Stevens et al., 
2005). Munc13 deletion mutant chromaffin cells have not been studied so far. However, 
in C. elegans, Unc-13 does not appear to be necessary for LDCV secretion. Rather, a 
distant relative of Munc13s, Unc-31/CAPS is necessary for LDCV secretion in C. 
elegans (Speese et al., 2007; Zhou et al., 2007).  
 
 
1.3 Munc13-4 and Baiap3/Bap3  
 Munc13-4 was identified as a distant Munc13 homologue in protein profile searches for 
proteins with MHDs (Koch et al., 2000). Together with Baiap3/Bap3, which was 
identified in the same profile search, it forms a subfamily of Munc13-like molecules, in 
which the typical Munc13-like domain structure is conserved (Figure 5). Munc13-4 is 






and to alveolar type II cells, which are both cell types with a secretory function, and in 
lymphocytes (Koch et al., 2000).  
 Loss-of-function mutations in the human Munc13-4 gene cause familial 
hemophagocytic lymphohistiocytosis type 3 (FHL3). At the functional level, these 
mutations appear to cause defective cytolytic granule exocytosis. Further analyses 
showed that human Munc13-4 is involved in a late step of the cytolytic granule 
exocytosis pathway, downstream of Rab27a (Feldman et al., 2003). Indeed, Munc13-4 
binds directly to Rab27a, whose mutation causes Griscelli Syndrome type 2 (GS2), a 
genetic disorder involving life-threatening defects of cytotoxic T lymphocytes. 
 Munc13-4 and Rab27a are highly expressed in cytotoxic T lymphocytes and mast cells, 
where they colocalize at secretory lysosomes. Overexpression of Munc13-4 enhances 
degranulation of secretory lysosomes in mast cells, which indicates that it has a positive 
regulatory role in secretory lysosome fusion (Neeft et al., 2005). Thus, Munc13-4 
appears to be essential for the priming of cytolytic granules, much like Munc13s 1-3 
mediate priming of SVs. 
 Baiap3/Bap3 (Brain-specific Angiogenesis Inhibitor 1-Associated Protein 3) is 34% 
identical to Munc13-4 (Koch et al., 2000). Baiap3/Bap3 was first identified as an 
interactor of the cytoplasmic region of BAI 1 (Brain-specific Angiogenesis Inhibitor 1), 
which is the product of a p53 target-gene, which encodes a seven span transmembrane 
protein, and which is specifically expressed in brain (Shiratsuchi et al., 1998).  
 The function of Baiap3/Bap3 is currently unknown. It is expressed predominantly in 
hypothalamus, amygdala, periaqueductal grey, septum and several brainstem nuclei. 
Analyses of deletion mutant fragments of Baiap3 showed that the interaction between 
Baiap3/Bap3 and BAI1 is dependent on the MHDs of Baiap3/Bap3 but not on the 
flanking C2 domains (Shiratsuchi et al., 1998). Interestingly, the Baiap3/Bap3 interactor 






which regulates synaptic neurotransmitter release (Krasnoperov et al., 1997; Lelianova 
et al., 1997).  
 So far, Baiap3/Bap3 has mostly been studied in the context of cancer development. The 
Baiap3/Bap3 promoter specifically binds the transcription factor EWS (Ewing’s 
sarcoma)-WT1 (Wilms’ tumor suppressor 1), which can transactivate a number of genes 
implicated in cellular differentiation. Baiap3/Bap3 is expressed in secretory 
syncytiotrophoblast cells of the placenta and in epithelial cells of the breast and 
prostate, and it is colocalized with a secreted growth factor within cytoplasmic 
organelles. Ectopic expression of Baiap3/Bap3 in tumor cells dramatically enhances 
growth in low serum and colony formation in soft agar assays. Interestingly, the 
Baiap3/Bap3 gene encodes a transcriptional target of an oncogenic fusion protein and 
regulates the exocytotic pathway in cancer cell proliferation (Palmer et al., 2002). In 
summary, the role of Baiap3 may be rate limiting for selected steps in the secretory  
pathway of specific cell types (Chan and Weber, 2002). However, the exact role of 
Baiap3/Bap3 in the control of SV or LDCV secretion and its relationship with other 
















1.4 The Aim of the Present Study: An Analysis of the Role of 
Munc13 Proteins and Baiap3/Bap3 in LDCV Exocytosis 
 The present study was performed with the aim to examine the role of Munc13 proteins 
and their relative Baiap3 in LDCV exocytosis. More specifically, my plan was to study 
LDCV secretion in mouse chromaffin cells in order to address the following two 
questions: 
1. Do Munc13s regulate LDCV priming? Studies in C. elegans indicated that the 
nematode Munc13-homlogue Unc-13 specifically regulates SV priming while the CAPS 
homologue Unc-31 mediates the corresponding priming effect in LDCV fusion (Zhou et 
al., 2007). These findings supported earlier studies in mammalian systems, which led to 
the conclusion that CAPS proteins are selectively responsible only for LDCV-mediated 
exocytosis (e.g. Tandon et al., 1998; Rupnik et al., 2000; Sadakata et al., 2004 and 
2007; Speese et al., 2007). However, a recent study in CAPS deficient mice clearly 
showed that CAPS proteins are absolutely essential for SV-mediated exocytosis 
(Jockusch et al., 2007), indicating that a restriction of CASPS/Unc-31-dependent 
regulatory processes to LDCV-mediated secretion may not exist in mammals. In order 
to complement these findings, my first aim was to test systematically whether in 
mammals the SV priming proteins Munc13-1, 2, and -3 are also important for LDCV 
priming.  
2. Does Baiap3/Bap3 play a Munc13-related role in LDCV priming? Baiap3/Bap3 is a 
distant Munc13 homologue of unknown function. In view of its homology with 
Munc13s and the published literature indicating that Munc13s may not be involved in 
LDCV secretion, I set out to examine whether Baiap3/Bap3, instead of Munc13s, 
controls LDCV priming in chromaffin cells. 
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 2.1.1 Munc13-1, Munc13-2 and Munc13-3 KO Mice 
 
 The Munc13-1, Munc13-2 and Munc13-3 deficient mice used in this study have been 
described previously (Augustin et al., 1999b; Varoqueaux et al., 2002; Augustin et al., 
2001). Chromaffin cells used in this study were cultured from pups on postnatal day 0 
(P0) if the mice were deficient for only one Munc13 isoform, whereas in the case of 
double and triple Munc13-1, -2 and -3 KO mice, cells were cultured on embryonic day 
18 (E18). For each experiment WT or heterozygous littermates were used as controls.  
 
PCR Genotyping for Munc13-1 
Primer 1 (#544): 5′-CTTACCCATCTGAGAGCCGGAATTCCA-3′  
Primer 2 (#5216): 5′-CTCCGAGGGGAATGCGCTTCCGTTTCCTG-3′ 
Primer 3 (#428): 5′-GAGCGCGCGCGGCGGAGTTGTTGAC-3′ 
Munc13-1 WT allele; 250 bp and Munc13-1 KO allele; 230 bp 
 
#: Primer number as designated by the AGCT DNA Core Facility, Max Planck Institute 
for Experimental Medicine, Germany.  
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Reaction Mixture   PCR Program   
 10X Buffer 2 µl  94 °C for 3 min  1 cycle 
 dNTPs 1 µl  94 °C for 30 sec 
 
Primer 1 2 µl  60 °C for 30 sec  
 Primer 2 1 µl  72 °C for 1 min 
 
30 cycles 
 Primer 3 1 µl  72 °C for 10 min 
 
1 cycle 
 Red Taq 1 µl  10 °C for forever 
 
1 cycle 
dH2O 11 µl     
Total 19 µl     




PCR Genotyping for Munc13-2 
Primer 4 (#1125): 5′-TCTCCACTGCCCCCTTTTACTGT-3′  
Primer 5 (#1124): 5′-TCAAGGGACTGTTCTAGCAATGTT-3′ 
Primer 6 (#428): 5′-GAGCGCGCGCGGCGGAGTTGTTGAC-3′ 
Munc13-2 WT allele; 322 bp and Munc13-2 KO allele; 349 bp 
 
 
Reaction Mixture   PCR Program   
 10X Buffer 2 µl  94 °C for 3 min  1 cycle 
 dNTPs 1 µl  94 °C for 30 sec 
 
Primer 4 2 µl  60 °C for 30 sec  
 Primer 5 1 µl  72 °C for 1 min 
 
30 cycles 
 Primer 6 1 µl  72 °C for 10 min 
 
1 cycle 
 Red Taq 1 µl  10 °C for forever 
 
1 cycle 
dH2O 11 µl     
Total 19 µl     
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PCR Genotyping for Munc13-3 
Primer 7 (#776): 5′-GGCTAGGAAGCAGGTAGTGATGGCTG-3′  
Primer 8 (#775): 5′-GCTTAACTGGAACTCACTGGATGTCAGAG-3′ 
Primer 9 (#495): 5′-GACGAGTTCTTCTGAGGGGATCGGC-3′ 
Primer 10 (#494): 5′-TACATTAGAGATGATAATTATCACACCCCAAAG-3′ 
Munc13-3 WT allele; 395 bp, and Munc13-3 KO allele; 410 bp 
 
Reaction Mixture   PCR Program   
 10X Buffer 2 µl  94 °C for 3 min  1 cycle 
 dNTPs 1 µl  94 °C for 30 sec 
 
Primer 7 2 µl  60 °C for 30 sec  
 Primer 8 1 µl  72 °C for 1min 
 
30 cycles 
 Primer 9 1 µl  72 °C for 10 min 
 
1 cycle 
 Primer 10 1 µl  10 °C for forever 
 
1 cycle 
Red Taq 1 µl     
dH2O 11 µl     
Total 19 µl     




2.1.2 Baiap3/Bap3 KO Mice 
 
 Baiap3 deficient mice were generated by Dr. Iris Augustin by homologous 
recombination in embryonic stem cells. Briefly, genomic sequences of Baiap3 were 
subcloned into the pTK-Neo vector. In the targeting vector a 500 bp genomic fragment 
containing exon 1-3 was replaced by a neomycin resistance gene. The vector also 
contained two copied of the herpes simplex virus thymide kinase for negative selection. 
Recombinant stem cell clones were identified by Southern blotting. Two positive clones 
were injected into mouse blastocytes to obtain highly chimeric mice that transmitted the 
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mutant gene through the germ line. Germ line transmission of the mutant gene was 
confirmed by southern blotting. Subsequent routine genotyping was performed by PCR. 
Western blot analyses of adult mouse brain homogenates with a Baiap3 specific 
antiserum directed against the N-terminus (a.a 9-181) or C-terminus (a.a 330-1150) of 
Baiap3, demonstrated the total absence of Baiap3 in homozygous mutant brain. 
Chromaffin cells from Baiap3 KO mice were cultured form P0 pups and WT littermates 
were used as controls. 
 
 
PCR Genotyping for Baiap3 
Primer 11 (#2862): 5′- CCAGAAATCCGCAGGCAGTCGTCA-3′  
Primer 12 (#2863): 5′- CAAGGCAACCACCAGCCGCATCTA-3′ 
Primer 13 (#2935): 5′- GAACACGGCGGCATCAGAGCAG-3′ 
Baiap3 WT allele; 546 bp and Baiap3 KO allele; 636 bp 
 
Reaction Mixture   PCR Program   
 10X Buffer 2 µl  94 °C for 1 min  1 cycle 
 dNTPs 1 µl  94 °C for 1 sec 
 
Primer 11 2 µl  60 °C for 30 sec  
 Primer 12 1 µl  72 °C for 30 sec 
 
33 cycles 
 Primer 13 1 µl  72 °C for 10 min 
 
1 cycle 
 Red Taq 1 µl  10 °C for forever 
 
1 cycle 
dH2O 11 µl     
Total 19 µl     
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2.2 In Vivo Assays 
 
 
2.2.1 Cell Culture and Transfection 
 
 
2.2.1.1 Cell Line Culture and Transfection 
 
 The HEK (Human Embryonic Kidney) 293FT cell line, an epithelial line derived from 
human embryonic kidney cells transformed with the large T-antigen, was used for both 
in vivo and in vitro binding assays. The cell line was maintained in plastic tissue culture 
dishes with high-glucose Dulbecco′s Modified Eagle′s Medium (DMEM) supplemented 
with 10 % fetal calf serum (FCS) in a 37 °C humid incubator with 5 % ambient CO2. 
The selection agent G418 (Geneticin) was added to complete DMEM medium of 
HEK293FT cells at a concentration of 500 µg/ml. Passaging was performed using 
standard procedures of trypsin mediated dislodgment of confluent cultures.  
1. For thawing cells, pre-warm the complete DMEM medium without G418 
2. Frozen vial from Liquid Nitrogen Tank, thaw the vial by gently shaking in a 
37°C water-bath 
3. Transfer the cells into 10 ml pre-warmed complete DMEM medium without 
Geneticin in a 50 ml falcon tube and mix slowly 
4. Centrifuge for 3 min at 800 rpm 
5. Carefully discard supernatant 
6. Wash the pellet with PBS and centrifuge a second time 
7. Resuspend the cells in 10ml of pre-warmed medium 
8. Transfer the suspended cells into T75 flask and incubate at 37 °C 
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9. One day before cells reach 90 % confluency, discard the medium from the T75 
flask 
10. Add 5 ml 0.05 % Trypsin and incubate for 5 min at 37°C 
11. Add 10 ml complete DMEM medium and triturate cells thoroughly 
12. Centrifuge for 3 min at 800 rpm 
13. Carefully discard supernatant 
14. Wash the pellet with PBS and centrifuge again 
15. Resuspend cells in 10 ml of pre-warmed medium 
16. Transfer suspended cells into 3 X T75 flask and incubate at 37 °C 
  
Transfections were performed using Lipofectamine 2000 by following standard 
procedures. 
1. For transfection of HEK293FT cells with either pMYC-Baiap3 full-length or 
pCDNA3-Munc13-1 full-length constructs, plate 6-7 X 105 cells in 15 ml of 
complete DMEM medium (for 15 cm dish format). Cells will be 85-90 % 
confluent at the time of transfection 
2. For transfection samples, dilute 30 µg of DNA (each construct) in 1.5 ml of 
Opti-MEM I without serum and gently mix.  
3. Mix Lipofectamine 2000 gently before use, dilute 60 µl of Lipofectamine 2000 
in 1.5 ml Opti-MEM I and incubate for 5min at RT 
4. Combine the diluted DNA with the diluted Lipofectamine 2000. Mix gently and 
incubate for 20 min at RT 
5. Add the DNA-Lipofectamine complexes to each dish  
6. Incubate the cells at 37 °C in a CO2 incubator for 30 hr prior to testing for co-
sedimentation 
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Complete DMEM medium: DMEM  
 10 % FCS 
 0.1 mM Non-Essential Amino Acids  
 2 mM L-glutamine 
 500 µg/ml G418 




2.2.1.2 Mouse Chromaffin Cells Culture 
 
 Embryonic (E18) and/or postnatal (P0) adrenal glands were dissected and chromaffin 
cells prepared by digestion with Papain solution. The adrenal glands were incubated 
with 400 µl papain solution at 37 °C for 30 min in Eppendorf Thermocycler (500 rpm), 
followed by addition of 400 µl stop solution and incubation for 15 min. The solution 
was then replaced by 500 µl complete NBA (Neurobasal-A) medium. The adrenal 
glands were gently opened before digestion, and triturated gently through a 10 µl pipette 
tip. The entire cell suspension obtained from two glands (one animal) was plated on a 
sterile coverslip in a 6-well plate. The cells were incubated at 37 °C and 5 % CO2 and 
used within 2 days after plating. 
Complete NBA medium: 500 ml NBA medium 
 10 ml B27 
 5 ml Glutamax 
 1 ml Penicillin/Streptomycin 
Papain Solution: 250 ml DMEM medium 
 50 mg L-Cystein 
 2.5 ml 0.1M CaCl2 
 2.5 ml 50mM EDTA 
 20 units/ml papain 
Stop Solution: 225 ml DMEM medium 
 25 ml heat inactivated FCS 
 625 mg Albumin 
 625 mg Trypsin inhibitor 
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2.2.2 SFV Preparation and Infection 
 
 SFV1 constructs expressing a Munc13-1-EGFP fusion protein have been described 
previously (Ashery et al., 2000). A Baiap3-IRES-EGFP construct was sub-cloned blunt-
ended into the SmaI site of the pSFV1 polylinker. Following linearization with SpeI, 
cDNAs of pSFV-Baiap3-IRES-EGFP, pSFV-Munc13-1-EGFP, and pSFV-helper1 were 
transcribed in vitro with SP6 RNA polymerase. BHK21 cells, derived from hamster 
kidney, were then transfected by electroporation (400 V, 975 µF) with a combination of 
10 µg of each constructs and incubated at 37 °C, 5 % CO2 for 24 hr. Following this 
incubation, the supernatant was collected and clarified from cell debris by low speed 
centrifugation. The supernatant containing the inactivated virus was snap-frozen in 450 
µl aliquots and stored at -80 °C. To test the virus titer, an aliquot was thawed and 
activated. BHK21 cells were then infected with various dilutions of the activated virus, 
and the infection efficiency was determined by assessing EGFP fluorescence. Four 
hundred and fifty microliters of frozen virus were thawed and diluted 1:1 with opti-
MEM medium with 2.5 % FCS. To activate the virus, 110 µl Chymotrypsin was added 
and incubated for 35 min at RT. In order to inactivate the chymotrypsin, 110 µl 
Aprotinin was added, incubation continued for an additional 5 min at RT. Infection was 
performed on cultured cells 24 hr after preparation according to published protocols 
(Ashery et al., 1999).  
 
To generate viral RNA for electroporation of BHK21 cells: 
1. Linearize DNA with SpeI enzyme 
2. Linearized DNA purification using phenol-chloroform extraction 
3. Precipitate DNA using 3M sodium acetate after purification 
4. In vitro transcription using SP6 trancription Kit  




    32 
5. RNA purification using phenol-chloroform extraction 
6. Precipitate RNA using 3M sodium acetate after purification 
7. Check RNA on formaldehyde-agarose gel 
8. Quantification of RNA concentration 
9. Transfection with BHK21 cells using electroporation 
10. Culture BHK21 cells for 2 days and then harvest the inactive virus 
11. Make 450 µl aliquots into cryotubes and freeze in liquid nitrogen 
12. Store at -80 °C until use 
 
To activate the SFV: 
1. Take one 450 µl virus aliquot and thaw 
2. Add 450 µl BHK21 cell medium  
3. Add 110 µl Chymotrypsin and mix and incubate for 35 min at RT 
4. Add 110 µl Aprotinin and mix and incubate for 5 min at RT 
5. Store at 4 °C 
 
 
DEPC-treated distilled water : 0.1 % DEPC (under hood) in dH2O 
 Stir for 2hr under hood and autoclave 
5X MOPS Buffer: 0.1 M MOPS 
 40 mM sodium-acetate 
 5 mM EDTA (pH 8.0) 
3M Sodium Acetate: 20.4 g of Sodium acetate trihydrate  
 Adjust to pH 5.8 
RNA gel loading buffer : 1X MOPS 
 6.5 % Formaldehyde 
 50 % Formamide 
 5 % Glycerin 
 0.1 mM EDTA 
 0.025 % Bromophenol Blue 
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BHK Cell Medium : 500 ml DMEM medium 
(for growth) 12.5 % FCS 
 1 ml Penicillin/Streptomycin 
BHK Cell Medium : 500 ml NBA medium 
(for electroporation) 10 ml B27 
 1 ml Penicillin/Streptomycin 
 1 ml Glutamax 
Chymotrypsin: 2 mg/ml  




2.2.3 Protein Extraction from Whole Brain and Adrenal Gland  
 
 Both whole brain and adrenal gland were taken from WT and Baiap3 KO mice and 
homogenized with a Glass-Teflon-Homogenizer in 4 °C in Lysis buffer. Total protein 
concentration was determined by a BCA protein assay and adjusted to 1-2 mg/ml in 
Sample Buffer (1x Laemmli Buffer). Prepare the samples for loading by heating them to 
100 °C for 5 min in Sample Buffer to denature the proteins. 
 
 
Lysis Buffer: 320 mM Sucrose 
 150 mM NaCl 
 1 mM EGTA (pH 8.0) 
 0.2 mM PMSF 
 1 µg/ml Aprotinin 
 1 µg/ml Leupeptin 
3X Sample Buffer: 10 % SDS 
 140 mM Tris/HCl (pH 6.8) 
 3 mM EDTA 
 30 % Glycerol 
 0.1 % Bromophenol Blue 
 150 mM DTT before use 
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2.3.1 Construct Subcloning 
 
 
2.3.1.1 Restriction Enzyme and Purification 
 For the construction of some constructs the gene of interest was amplified by PCR and 
subsequently digested with the appropriate restriction enzymes. Digested DNA 
fragments were purified by using phenol-chloroform extraction before subcloning using 
the following procedures: 
1. Amplify DNA and digest with the appropriate restriction enzymes 
2. To purify of the DNA, add 200 µl Phenol-chloroform-isoamylalcohol (25:24:1) 
(pH 7.5-8 for DNA; pH 4-6 for RNA). Mix by pipetting up and down 
3. Add 200 µl Chloroform and vortex thoroughly 
4. Centrifuge at 15000 rpm for 5 min (DNA is in upper phase) 
5. Transfer the supernatant into new eppendorf tube 
6. Add 200 µl chloroform and mix with vortexer 
7. Centrifuge at 15000 rpm for 2 min  
8. Transfer the supernatant into new eppendorf tube 
9. Add 1/10 volume of 3M Ammonium-acetate  
10. Add 2.5 volume of 100 % cooled EtOH and mix 
11. Incubate at -20 °C for ON 
12. Centrifuge at 15000 rpm for 30 min 
13. Wash the pellet with -70 % cooled EtOH 
14. Centrifuge at 15000 rpm for 10 min 
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15. Carefully remove supernatant and dry the pellet 
16. Add 50 µl dH2O to resuspend and quantify 
 
 
2.3.1.2 Dephosphorylation, Ligation and DNA-sequencing 
 Prior to ligation of insert DNA and vector DNA, the 5' ends of the vector were 
dephosphorlyated by Shrimp Alkaline Phosphatase. Ligation was performed using T4 
DNA ligase. After transformation, plasmid DNA was prepared from cultures grown 
from colonies, analyzed by restriction digests and plasmid DNA from selected clones 
was sequenced by the Applied Biosystems 373 DNA sequencer by the DNA core 
facility. 
 
1. For dephosphorylation, add 2.5 µl dephosphorylation buffer and 2 µl 
phosphatase in 20.5 µl purified DNA 
2. Incubate for 10 min (for sticky ended) or 1 hr (for blunt ended) at 37 °C 
3. Inactivate the Shrimp Alkaline Phosphatase for 15 min at 65 °C 
4. For the ligation reaction, a 1:5 to 3:8 (vector: insert) ratio is usually used and 
ligations are placed in 4 °C water-bath that warms up to 15°C ON 
5. Transformation into E.coli 
 
 
2.3.2 Western Blotting  
 
2.3.2.1 SDS gel Electrophoresis of Proteins  
 In order to investigate subunit compositions and to verify homogeneity of protein 
samples, electrophoresis is used to separate complex mixtures of proteins. Proteins 
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migrate in response to an electrical field through pores in the gel matrix. The 
combination of gel pore size and protein size and charge determines the migration rate 
of the proteins. SDS-PAGE is an anionic system due to the negatively charged SDS. 
 
1. Pour gel of appropriate polyacrylamide concentration, depending on molecular 
weight of the protein of interest 
2. Mount the gel in the electrophoresis apparatus and fill with running buffer (1X 
RB) 
3. Load the prepared samples into the wells  
4. Attach the electrophoresis apparatus to an electric power supply. Apply a current 
of 25 mA and 50 mA for one and two gels, respectively 
5. After running the gel, place the polyacrylamide gel in a plastic container for 
either coomassie staining or blot transfer to membranes 
 
Stacking gel: 1 M Tris-HCl (pH 6.8)  Separating gels 
Separating gel: 1.5 M Tris-Hcl (pH 8.8)  7.5 % gel: > 100 kDa 
Acrylamide/Bisacrylaminde: 30 % Acrylamid/Bis (37.5:1)  10 % gel: 60~130 kDa 
SDS: 10 % Stock solution  13 % gel: 20~80 kDa 
APS 10 % Stock solution  15 % gel: < 50 kDa 
TEMED: Solution from SERVA   
10X RB: 250 mM Tris   
 2.5 M Glycine (pH 8.3)   




2.3.2.2 Coomassie Blue Staining 
 An easy and rapid detection method for proteins in gel is to perform a coomassie blue 
staining of the polyacrylamide gel. It is based on nonspecific binding of the dye 
coomassie brilliant blue R250 to proteins. The detection limit is 0.3 to 1µg/protein band.  
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1. Place the polyacrylamide gel in a plastic container and cover it with 5 volumes 
of Coomassie staining solution A. 
2.  Incubate for 1 min at 100 °C using Microwave 
3. Remove solution A and add Coomassie staining solution B. Incubate for 1 min 
at 100 °C using Microwave 
4. Remove solution B and add Coomassie staining solution C. Incubate for 1 min 
at 100 °C using Microwave 
5. Remove solution C and add Coomassie staining solution D. Incubate for 1 min 
at 100 °C using Microwave  
6. Pour out Coomassie staining solution D. Keep the gel at RT 
 
Coomassie staining solution A: 0.15 % Coomassie Brillant Blue R25 
 25 % Isopropanol 
 10 % Acetic Acid 
Coomassie staining solution B: 0.015 % Coomassie Brillant Blue R25 
 10 % Isopropanol 
 10 % Acetic Acid 
Coomassie staining solution C: 0.006 % Coomassie Brillant Blue R25 
 10 % Acetic Acid 





2.3.2.3 Blot Transfer of Protein Gels to Membranes 
 The membranes used for the electrophoretic transfer were manufactured from 
nitrocellulose. In this procedure, blotting is performed in a tank of buffer with the gel in 
a vertical orientation, completely submerged between two large electrode panels as 
follows: 
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1. Assemble transfer sandwich; one plastic support, one porous pad, two pieces of 
Whatman paper, nitrocellulose, gel, two pieces of Whatman paper, one porous 
pad, and a plastic support. The transfer cassette should be assembled under 
buffer to avoid trapping of air bubbles 
2. Fill tank with transfer buffer and place the sandwich into electroblotting 
apparatus. Transfer is achieved by applying a current of 40 mA for 16 hr at 4°C 
in a cold room 
 
Transfer Buffer: 25 mM tris-HCl (pH 8.3) 
 190 mM Glycine 




2.3.2.4 Immunoblotting with ECL (Enhanced Chemiluminescence) 
 ECL uses the HRP (hydrogen peroxide) catalyzed oxidation of luminol in alkaline 
conditions. Immediately following oxidation, the luminol is in an excited state which 
then decays to ground state via a light emitting pathway. ECL is achieved by 
performing the oxidation of luminol by the HRP in the presence of chemical enhancers 
such as phenols. This increases the light output approximately 1000 fold and extends 
the time of light emission. The maximum light emission is at a wavelength of 428 nm, 
which can be detected by a short exposure to blue-light sensitive autoradiography film. 
The detection limit of the ECL system is less than 1 picogram (pg) of antigen 
Procedures used were as follows: 
 
1. Pour 10 ml of Buffer A onto membrane and incubate for 1 hr at RT or for ON at 
4 ºC on an orbital shaker to block non-specific binding 
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2. Dilute the primary antibody in Buffer A and incubate the membrane for 1 hr at 
RT 
3. Wash the membrane three times for 15 min in Buffer B at RT 
4. Dilute the secondary antibody in Buffer A and incubate the membrane for 1 hr at 
RT 
5. Wash the membrane three times for 15 min in Buffer B at RT 
6. Wash the membrane three times for 15 min in Buffer C at RT 
7. Wash the membrane three times for 15 min in Buffer D at RT 
8. Mix an equal volume of ECL detection solution 1 with detection solution 2 to 
give sufficient volume in order to cover the membrane 
9. Incubate for 1 min at RT with mixed ECL solution 
10. Drain off excess detection reagent and cover the filter with a copier transparency 
11. Check the signal by exposing the membrane to an autoradiography film in a dark 
room 
 
10X Transfer Buffer: 1.92 M Glycine 
 250 mM Tris 
10X TBS: 1.37 M NaCl 
 200 mM Tris-HCl, pH 7.6 
Tween 20 stock solution: 10 % Tween 20 
Buffer A: 5 % goat serum 
 5 % milk powder 
 0.1 % Tween 20 
 1X TBS 
Buffer B: 5 % milk powder 
 0.1 % Tween 20 
 1X TBS 
Buffer C: 0.1 % Tween 20 
 1X TBS 
Buffer D: 1X TBS 
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2.3.3 Northern Blotting 
 
2.3.3.1 RNA Extraction 
 To check the expression level of Baiap3 RNA in WT and Baiap3 KO mice, total RNA 
was isolated from littermates as follows: 
1. Homogenize whole brain from WT and Baiap3 KO mice in Trizol reagent using 
a Glass-teflon homogenizer 
2. Store the homogenate for 10 min at RT 
3. Add chloroform and shake vigorously 
4. Store the mixture at RT for 15 min and centrifuge at 15000 rpm for 15 min at 
4°C 
5. RNA remains exclusively in the aqueous phase and is transferred into a new 
tube 
6. Add isopropanol and mix vigorously 
7. Store the mixture at RT for 10 min and centrifuge at 15000 rpm for 10 min at 
4°C 
8. Remove the supernatant and wash the RNA pellet with 75 % EtOH 
9. Centrifuge at 15000 rpm for 5 min at 4 °C 





 The RNA extracted from whole brain of WT and Baiap3 KO littermates was used to 
detect Baiap3 RNA using a specific probe corresponding to a region of the gene that is 
not deleted in the Baiap3 KO (a.a 330-1150). RNA is transferred from an agarose gel to 
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a Hybond+ (nucleic acid transfer) membrane by capillary transfer. The blots are 
analyzed by hybridization analysis with a radioactively labeled DNA probe as follows: 
 
1. Prepare RNA samples with 10X MOPS, 12.3 M formaldehyde, and formamide 
2. Incubate for 15 min at 55 °C and add formaldehyde loading buffer 
3. Load the prepared RNA samples onto a formaldehyde agarose gel 
4. Run the gel at 80 V for 4 hr in 1X MOPS 
5. Transfer the gel into a new plastic container with 1L 20X SSC and soak for 
45min 
6. For blot, Cut three pieces of 3 M paper and the Hybond+ (nucleic acid transfer) 
membrane to cover the exposed surface of the gel 
7. Incubate for overnight in 0.4 N NaOH 
8. Wash the membrane with 1X SSC until the pH reaches 7.5 and dry the 
membrane 
9. Cross link the RNA to the membrane with UV light (1 J/Cm2) 
10. Pre-wet the membrane with 2XSSC and place in hybridization bottle, add 
hybridization solution and incubate at 65 °C for 30 min 
11. Prepare labeled probe with 32PdCTP 
                   25 ng of DNA          1 µl 
                   dH2O                     23 µl 
                   Random primer      10 µl  
12. Incubate for 5 min at 100 °C 
13. Add 10 µl 5 X buffer and 5 µl 32PdCTP and 1ul Exo-Klenow and incubate for 10 
min at 37 °C 
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14.  Add 2 µl Stop mix and purify the labeled probe with Bio-Spin 6 column and 
Incubate for 6 min at 100 °C 
15. Store the probe on ice for 10 min 
16. Add labeled probe to the membrane and incubate ON at 65 °C 
17. Wash the membrane with 2X SSC + 0.1 % SDS at RT for 20 min 
18. Wash the membrane with 1X SSC + 0.1 % SDS at 65 °C for 20 min 
19. Wash the membrane with 0.5X SSC + 0.1 % SDS at 68 °C for 30 min 
20. Check the radioisotope activity and wash until counts are below 100 
21. Expose the membrane with film at -80 °C for 3 days  
 
10X MOPS: 0.4 M MOPS (pH7.0) 
 0.1 M sodium acetate 
 0.01 M EDTA 
20X SSC: (pH7.0) 3 M NaCl 
 0.3 M Na3citrate.2H2O 
Formaldehyde loading buffer: 1 mM EDTA (pH8.0) 
 0.25 % bromophenol blue 
 0.25 % xylene cyanol 
 50 % glycerol 
Formaldehyde gel (100ml): 1 g Agarose in 72ml dH2O 
 10 ml 10XMOPS 




2.3.4 Expression of GST Fusion Proteins 
 
 In order to express with either Munc13-1 or Sytaxin 1A (a.a 1-256) or Baiap3-MHDs 
(a.a 330-1150) fusion proteins with GST, BL21DE3 E.coli was subjected to 
electroporation-mediated plasmid transformation with the respective constructs in 
pGEX-KG. GST-fusion proteins were prepared by follows; 
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1. Inoculate one colony from LB- ampicillin plates with either GST-Munc13-1 or 
GST-Syntaxin 1A (a.a 1-256) or Baiap3-MHDs (a.a 330-1150) into individual 5 
ml of LB broth containing ampicillin and grow ON at 37 °C with shaking. 
2. Inoculate 1 L of LB with 5ml from step 1 
3. Grow at 37 °C with shaking for 4 hr 
4. Induce expression of the protein by adding 0.3 mM IPTG and incubate for 4 hr 
at 25 °C with shaking 
5. Centrifuge the culture at 3500 g for 20 min at 4 °C 
6. Discard the supernatant and resuspend the pellet in 20 ml PBS with protease 
inhibitors 
7. Add Lysozyme and incubate for 10 min at RT 
8. Sonicate the bacterial suspension on ice, three times in short 30 sec bursts  
9. Add 1 % Sodium cholate and incubate for 10 min at 4 °C with shaking 
10. Centrifuge the lysate at 15000 g for 15 min at 4 °C 
11. Transfer the supernatant to a fresh tube 
12. Add 1 ml of a 50:50 slurry of Glutathione-Sepharose 4B beads in lysis buffer 
and incubate for ON at 4 °C 
13. Centrifuge at 750 g for 5 min at 4 °C to pellet the beads 
14. Wash the beads four times in 5 ml of cold wash buffer 
15. The fusion protein should be stored on the beads at 4 °C  
 
Ampicillin Solution: 20  mg/ml 
Kanamycin Solution: 10  mg/ml 
LB-Medium: 10 g NaCl 
 10 g Bacto-Trypton 
 5 g Bacto-Yeast-Extract 
 In 1 L dH2O and Autoclave 
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LB-Plate: 15 g Bacto-Agar 
 In 1 L LB Medium 
 appropriate antibiotic selection 
50X TAE: 242 g Tris Base 
 57.1 ml Acetic acid 





2.3.5 Co-sedimentation Assays  
  
 Recombinant fusion proteins consisting of glutathione S-transferase fused to syntaxin 
1A (a.a 1-256), Munc13-1-176/178 (a.a 517-1735), Munc13-1-N1/N2 (a.a 3-317), 
Munc13-1-13'1 (a.a 1032-1345), or Munc13-1-3'13A (a.a 1399-1622) (Betz et al., 1997) 
were produced in E. coli using the pGEX-KG expression vector. Recombinant proteins 
were purified on glutathione-sepharose 4B, and immobilized on the resin for co-
sedimentation assays. Cell lysate from HEK293FT cells co-transfected with pEGFP-
Munc13-1 (full-length) and pMYC-Baiap3 (full-length) or crude whole brain extract 
from adult WT mice was solubilized at a concentration of 2 mg/ml in lysis buffer. After 
stirring on ice for 10 min, insoluble material were removed by centrifugation at 15000 
rpm for 30 min at 4 °C. The equivalent of 3 mg of total protein was incubated with 50 
µg immobilized GST-fusion protein ON at 4 °C on a rotating wheel. Beads were 
washed 4 times with lysis buffer, resuspended in SDS-PAGE sample buffer, and 
analyzed by SDS-PAGE and immunoblotting using standard procedures. 
Immunoreactive proteins were visualized with ECL. The following primary antibodies 
were used for immunodetection: two monoclonal antibodies to MYC for Baiap3, to 
Syntaxin 1A/B, and a polyclonal antibody to Munc13-1. 
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2.3.6 Production of Anti-Baiap3 Antisera 
  
 Polyclonal antibodies directed against Baiap3 were generated with a GST fusion 
protein as the antigen. Recombinant GST-Baiap3-MHDs fusion protein was generated 
by using the expression plasmid pGEX-Baiap3-MHDs, which expresses the residues 
330-1150 of Baiap3 in the pGEX-KG vector. A polyclonal antibody that recognizes the 
N-terminus of Baiap3 (a.a 9-181) had previously been generated by Dr. Iris Augustin. 
Since the antibody produces a rather high background in immunofluorescence staining, 
we generate an antibody to a.a 330-1150 of Baiap3. We subcloned the regions spanning 
the MHDs to up to C2C domain of Baiap3 into the pGEX-KG construct. The host 
immunization and bleeding of rabbits and guinea pigs was performed by Eurogentec. 
The antisera were derived from the final bleeding of the rabbits SA5990 and SA5991 
and of the guinea pigs SAC106 and SAC107. Since the recombinant Baiap3 protein 
proved to be insoluble and furthermore stuck to the beads, the following purification 
procedures were used: 
 
Subcloning of the Baiap3 MHDs 
Primer 14 (#11742): 5′-CCGGAATTCTAATGAACTTAGAGGTGGCCTCGG-3′  
Primer 15 (#3417): 5′-TACGCGTCGACTCACCGGTTCTGCTCCAG-3′ 
 
Reaction Mixture   PCR Program   
 10X Buffer 10 µl  94 °C for 3 min  1 cycle 
 dNTPs 5 µl  94 °C for 30 sec 
 
Primer 14 4 µl  55 °C for 30 sec  
 Primer 15 4 µl  72 °C for 1min 
 
35 cycles 
 Pfu Taq 1 µl  72 °C for 10 min 
 
1 cycle 
 dH2O 25 µl  10 °C for forever  1 cycle 
Total 50 µl     
Template DNA 1 µl     
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1. Inoculate one colony from LB-ampicillin plates with GST-Baiap3-MHDs into 
individual 5 ml of LB broth containing ampicillin and grow ON at 37 °C with 
shaking incubator 
2. Inoculate 1 L of LB with 5 ml from step 1 
3. Grow at 37 °C with shaking for 4 hr 
4. Induce expression of the protein by adding 0.3 mM IPTG and incubate for 4 hr 
at 25 °C with shaking 
5. Centrifuge the culture at 3500 g for 20 min at 4 °C 
6. Discard the supernatant and resuspend the pellet in 20 ml PBS with protease 
inhibitors 
7. Add Lysozyme and incubate for 10 min at RT 
8. Sonicate the bacterial suspension on ice, three times in short 30 sec bursts  
9. Add 1 % sodium cholate and incubate for 10 min at 4 °C with shaking 
10. Centrifuge the lysate at 15000 g for 15min at 4 °C 
11. Transfer the supernatant to a fresh tube 
12. Add 1 ml of a 50:50 slurry of Glutathione-Sepharose 4B beads in lysis buffer 
and incubate for ON at 4 °C 
13. Centrifuge at 750 g for 5 min at 4 °C to pellet the beads 
14. Wash the beads four times in 5 ml of cold wash buffer 
15. Cleave between GST and Baiap3 fragment by thrombin digestion for 2 hr at RT 
16. Protein purification from the beads by Electro-HPLC (high performance liquid 
chromatography) 
17. The denatured purified Baiap3 fragment was sent to Eurogentec for 
immunization 
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2.3.7 Antibodies, Chemicals, Kits and Reagents 
 
Antibodies   
Primary monoclonal Source Dilution  
Anti-ChromograninA  BD Biosciences 1:1000 
Anti-MYC Abcam 1:3000 
Anti-NMDA R1 Synaptic Systems 1:1000 
Anti-NSF Abcam 1:2000 
Anti-SNAP 25  Synaptic Systems 1:2000 
Anti-Synaptobrevin2  Synaptic Systems 1:2000 
Anti-Synaptophysin Synaptic Systems 1:2000 
Anti-Syntaxin1  Synaptic Systems 1:2000 
Anti-Tubulin Sigma 1:10.000 
   
Primary polyclonal Source Dilution  
Anti-BAI 1 Abcam 1:1000 
Anti-Baiap3   Shin et al. 1:500 
Anti-Munc13-1 (40.1) Varoqueaux et al. 1:1000 
Anti-bMunc13-2 (44.1) Varoqueaux et al. 1:1000 
Anti-ubMunc13-2 (48.1) Varoqueaux et al. 1:1000 
Anti-Munc13-3 (52.1)  Varoqueaux et al. 1:1000 
Anti-Munc18-1 Synaptic Systems 1:2000 
Anti-VMAT2 Weihe et al. 1:2000 
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Ampicillin Sigma-Aldrich 
Aprotinin Roche 
Bacto-Yeast-Extract DIFCO Laboratories 
Bacto-Trypton DIFCO Laboratories 
Bacto-Pepton DIFCO Laboratories 
Bacto-Agar DIFCO Laboratories 
BAPTA Signa-Aldrich 
BCA (Protein Assay) Bio-Rad 
Bromophenol Blue Sigma-Aldrich  
Coomassie Blue R250 BIOMOL 
Chymotrypsin Sigma-Aldrich  
[α
32
P]dCTP Amersham  
DEPC Sigma-Aldrich  
DMSO  Sigma-Aldrich 
dNTP´s Pharmacia Biotech 
DTT Sigma-Aldrich  
ECL-Reagents Amersham-Buchler 
Films Kodak  
Ethanol JT Baker 
Ethidiumbromide Sigma-Aldrich 
Ficoll 400 Pharmacia Biotech 
Fura-4F Invitrogen 
Glutathion Sepharose 4B Sigma-Aldrich 
Glutathion-Agarose Matrix Sigma-Aldrich 
Glycin Bio-Rad Laboratories 






Ni-NTA-Agarose-Matrix Qiagen  
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PMSF Roche 
Ponceau S Sigma-Aldrich 
Protein Assay Bio-Rad Laboratories 
Proteinase K Boehringer Mannheim  
Rapid-hyb. Buffer Amersham pharmacia 
Rat Quick Clone cDNA, MouseBrain Clontech 
SDS Roche 






Tris Base Sigma-Aldrich 
Triton X-100 Roche 
Dry Milk Nestle 





Centricon 10 Amicon GmbH 
ECL-film Amersham 
Electroporation Cuvettes Bio-Rad Laboratories 
Hybond-N+-Membrane Amersham 
Plasmid-Purification Kit Qiagen 
Prime-It II-Random Primer Labelling Kit Stratagene  
Protran (nitrocellulose transfer membrane) Whatman International 
Shrimp Alkaline Phosphatase Roche 
SP6 in vitro transcription Kit Roche 
Topo T/A und Topo XL Cloning Kit Invitrogen 
Qiafilter Plasmid Kit Qiagen 
Qiaquick Gel-Extraction Kit Qiagen 
Qiaquick PCR-Purification Kit Qiagen 
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Reagents   
Product Company 
β-Mercaptoethanol "cell culture tested" Sigma-Aldrich  
DMEM Gibco-BRL 
Knockout DMEM  Gibco-BRL 
Fetal Calf Serum Hyclone 
Fetal Bovine Serum Hyclone 
G418 Invitrogen 
L-Cysteine Gibco-BRL 
L-Glutamine (100 x) Gibco-BRL 
Lipofectamin 200 Invitrogen 
NEAA (100 x) Gibco-BRL 
Neurobasal Medium Gibco-BRL 
Papain Worthington 
Penicillin/Streptomycin  Gibco-BRL 
Opti-MEM Gibco-BRL 
Trypsin-EDTA (0.05x) Gibco-BRL 





2.4 Electrophysiological Analysis 
 
 
2.4.1 Whole Cell Capacitance Measurements 
  
 Conventional whole-cell recordings were performed at 30 °C with 3-5 MΩ pipettes 
(Kimax-51; Kimble/Kontes, Vineland, NJ) (Voets et al., 2000). An EPC-9 patch-clamp 
amplifier was used together with the Pulse software package (HEKA Electronics, 
Lambrecht, Germany). Capacitance measurements were performed by using the Lindau-
Neher technique implemented as the “sine+ dc” mode of the software lock-in extension 
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of pulse, which allowed long-duration capacitance measurements in a single sweep. A 
1000 Hz, 70 mV peak-to-peak sinusoid voltage stimulus was superimposed onto a DC 
holding potential of -70 mV. Currents were filtered at 3 kHz and sampled at 12 kHz.  
 The capacitance traces were exported to Axograph (Axograph Scientific, Sydney, 
Australia) for analysis. Displayed traces are averages for each condition, with the 
number of cells given in the figure legends. To control for variation between 
preparations, we always compared WT or heterozygous and KO chromaffin cells 
obtained from the same preparation. Kinetic data were obtained by fitting individual 
capacitance recordings with a sum of three exponential functions. 
 
10X External Solution: 1.4 M NaCl (pH 7.6) 
 (pH 7.2, 310-320 mOsm) 24 mM KCl 
 100 mM HEPES 
 100 mM Glucose 
 40 mM CaCl2 
 40 mM MgCl2 
  
Intracellular Solution 1:  120 mM CsCl 
For trains of short depolarizations 20 mM TEA-Cl 
(pH 7.2, mOsm:310) 1 mM CaCl2 
 2 mM MgCl2 
 11 mM EGTA 
 10 mM HEPES 
 2 mM Mg-ATP 
 0.5 mM Na-GTP 
Intracellular Solution 2:  110 mM Cs-glutamate 
For Flash photolysis 8 mM NaCl 
(pH 7.2, mOsm:310) 2 mM Mg-ATP 
 0.3 mM Na-GTP 
 20 mM Cs-HEPES 
 4.5 mM CaCl2 
 5 mM NP-EGTA 
 0.3 mM Mg2+-Fura-2 
 0.2 mM Fura-4F 
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2.4.2 Flash Photolysis of Caged Ca2+ and Measurements of [Ca2+] i  
  
 Flashes of UV light were generated by a flash lamp (Rapp Optoelektronik, Hamburg, 
Germany), and fluorescence excitation light was generated by a monochromator (TILL 
Photonics, Planegg, Germany) as described previously (Gillis et al., 1996; Xu et al., 
1998); these were coupled into the epifluorescence port of an inverted Axiovert 100 
microscope with a 40X Fluorobjective (Zeiss, Oberkochen, Germany). Mg2+-Fura-2 was 
excited at 380/340 nm, and the illumination area was reduced to cover only the diameter 
of the cell. Emitted light was attenuated with a neutral density filter, detected with an 
avalanche photodiode (TILL Photonics, Planegg, Germany), filtered at 3 kHz and 
sampled at 12 kHz by Pulse software (Ashery et al., 2000). The basal [Ca2+]i was 
measured to be 220 nM by fura-2 in vivo using calibration solution 1 (Rmin), solution 2 
(Rmax), solution 3 (Keff), and solution 4 (α-coefficient). The flash photolysis efficiency 
was also measured as described (Xu et al., 1998). The photolysis efficiency of a 350 V 
discharge flash for NP-EGTA was determined to be 30 %. Fluorescence excitation light 
was used to measure [Ca2+]i and simultaneously photorelease Ca2+ after the flashes in 
order to keep [Ca2+]i approximately constant. [Ca2+]i was calculated from the 
fluorescence ratio (R) according to Grynkiewiez et al (1985) and the flash photolysis 
efficiency was calculated as according to published protocols (Xu et al., 1998). 
Fluorescent excitation light was used not only to measure but also to adjust before and 
after flash. The basal Ca2+ concentration before the flash was 500-900 nM. 
 
 Each cell was patched under conditions as follows; 
1. Access resistance is low, preferably < 7 MOhm 
2. Leak current is low, preferably < 20 pA 




    53 
3. Fluorescence ratio is stable before the flash 
4. Loading with dye saturates, indicating the cell is not swelling excessively 
 
2X Pipette Solution: 250 mM Cs-glutamate 
  80 mM Cs-HEPES (pH 7.2) 
10X Nucleotide: 20 mM Mg-ATP 
 3 mM Na-GTP 
 10 mM HEPES (pH 7.2) 
Solution 1: 20 mM BAPTA 
 1X Pipette solution 
 1X Nucleotide 
 0.5 mM Fura-2 
Solution 2: 10 mM CaCl2 
 1X Pipette solution 
 1X Nucleotide 
 0.5 mM Fura-2 
Solution 3: 20 mM BAPTA 
 13.33 mM CaCl2 
 1X Pipette solution 
 1X Nucleotide 
 0.5 mM Fura-2 
Solution 4: 1X Pipette solution 
 1X Nucleotide 




2.4.3 Data Analysis and Statistics 
 
 Data were analyzed offline using AxoGraph 4.9 or AxoGraph X 1.0 (AxoGraph 
Scientific, Sydney, Australia) and Kaleidagraph 4.0 (Synergy Software, PA, USA). 










3.1 Analysis of the Role of the Munc13 Protein Family in LDCV 
Exocytosis  
 
3.1.1 Reduced Exocytosis in Chromaffin Cells from Munc13-1 KO Mice  
 Munc13-1 is expressed in bovine chromaffin cells, which are used as a model for 
LDCV secretion (Ashery et al., 2000) and is also present in mouse adrenal gland 
(Figure 16A). The role of Munc13-1 in SV exocytosis has been investigated in 
individual hippocampal primary neurons cultured on astrocyte feeder islands 
(microisland culture) (Augustin et al., 1999b). Munc13-1 deficient neurons showed a 
striking deficit in evoked and spontaneous neurotransmitter release. In present study, we 
investigated whether the absence of Munc13-1 affects exocytosis of LDCVs in mouse 
adrenal chromaffin cells (Figure 6F). We performed whole-cell patch clamp recordings 
combined with flash photolysis of caged Ca2+ on chromaffin cells cultured from P0 
adrenal glands. Flash photolysis of caged Ca2+ typically causes a biphasic increase in 
membrane capacitance. Upon photolysis of caged Ca2+, release was undetectable at Ca2+ 
concentration of < 1 µM, became measurable at 1-2 µM Ca2+, and resembled the release 
observed during a normal action potential at > 5 µM Ca2+, and saturated at > 20 µM 
Ca2+ (Bollmann et al., 2000). 
 We found that, in chromaffin cell from Munc13-1 KO mice, both the exocytotic burst 
and the sustained component were significantly reduced (Burst: by ∼40 %, and 
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Figure 6. Reduced exocytosis in chromaffin cells from Munc13-1 deficient mice. 
(A) Average ∆Cm in response to flash photolysis of NP-EGTA in chromaffin cells cultured at P0 from 
WT (28 cells from 5 mice, black line) and Munc13-1 KO mice (32 cells from 5 mice, orange line). The 
intracellular Ca2+ concentration following the flash is shown in the upper trace. (A′) The Munc13-1 KO 
trace was normalized to the WT amplitude at 4 s after the flash. (B-C) Comparison of the exocytotic burst 
(P=0.0007) and sustained release (P=0.0005) in WT control and Munc13-1 KO cells. The exocytotic 
burst and sustained release were determined as the ∆Cm 1 s and 2 s to 5 s after the flash, respectively. (D-
E) Kinetic analysis of the capacitance traces revealed that the two burst components, fast (P=0.032) and 
slow (P=0.035), are both reduced in amplitude, without any change in the time constant. Error bars 
indicate standard error of the mean. (F) Representative mouse chromaffin cell with attached glass pipette. 
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 In order to investigate the release kinetics of exocytosis, we fitted individual 
capacitance traces with a sum of exponentials within the first second after the flash. The 
amplitudes of the capacitance traces represent the vesicle pool sizes, whereas the time 
constants identify their fusion kinetics. The first phase, the exocytotic burst, can be 
further subdivided into a fast burst (fusion with a time constant of ∼20 ms at 20 µM 
Ca2+) and a slow burst (fusion with a time constant of > 200 ms at 20 µM Ca2+) 
components (Sørensen et al., 2003). These phases represent fusion of two distinct pools 
of docked and primed vesicles, the RRP and the SRP. The slow component or SRP 
represents a precursor state to the fast component or RRP and the sustained phase of 
secretion, which persists for several seconds, is thought to represent refilling of the 
primed vesicle pools (Voets et al., 1999). 
 
 In chromaffin cell from Munc13-1 deficient mice, we found that both the fast and the 
slow burst components were significantly smaller than in WT chromaffin cells, but that 
vesicle fusion kinetics were not affected (Figure 6D-E, Table 1). To examine whether 
the reduction in Munc13-1 KO exocytosis obscures a difference in the kinetics of the 
sustained phase, we normalized the traces to the sustained phase of release at 4 s (Figure 
6A′). However, no change in the kinetics of the sustained phase or the relative 
amplitudes of burst and sustained component were detected, indicating that the 
Munc13-1 deficiency impairs the docking/priming reactions necessary for the release of 
all vesicles, rather than affecting the burst phase or sustained phase selectively. 
Postflash [Ca2+]i was closely matched between KO and WT cells (Figure 6A, top), 
which shows that the release deficit in Munc13-1 KO chromaffin cells is not due to 
altered Ca2+ levels. These findings demonstrate that loss of Munc13-1 leads to a 
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recruitment of new LDCVs into this pool, without affecting the kinetics of the fusion 
step. 
   
 
 
3.1.2 Reduced Exocytosis in Chromaffin Cells from Munc13-2 KO Mice  
 Munc13-2 is expressed in bovine chromaffin cells (Zikich et al., 2008) and also in 
mouse adrenal gland (Figure 17A). To test whether Munc13-2 is required for exocytosis 
of LDCVs, we stimulated chromaffin cells obtained from P0 WT and Munc13-2 KO 
littermates using flash photolysis of caged Ca2+. We found that in chromaffin cells from 
Munc13-2 deficient mice, both the exocytotic burst and the sustained component were 
reduced (Burst: by ∼30 %, and Sustained: by ∼40 %; Figure 7A-C; Table 1), however, 
the reduction was statistically not significant (Figure 7). 
  
 When we investigated the release kinetics of exocytosis by fitting individual 
capacitance traces within the first 1 s after the flash with a sum of exponentials, we 
found that in chromaffin cell from Munc13-2 KO mice, both the fast and slow burst 
were reduced, but the reduction was statistically not significant (Figure 7D-E, Table 1). 
Like the loss of Munc13-1, loss of Munc13-2 also had no effect on the vesicular release 
kinetics during the exocytotic burst (Figure 7D-E, Table 1), nor did normalization of the 
traces to the sustained component reveal a selective alteration of the kinetics of the 
sustained component (Figure 7A′). Postflash [Ca2+]i was closely matched between KO 
and WT cells (Figure 7A, top). In cultured hippocampal neurons obtained from 
Munc13-2 KO mice, SV exocytosis was not affected, suggesting a compensatory effect 









Figure 7. Reduced exocytosis in chromaffin cells from Munc13-2 deficient mice. 
(A) Average ∆Cm in response to flash photolysis of NP-EGTA in P0 WT control (21 cells from 4 mice, 
black line) and Munc13-2 KO (22 cells from 4 mice, vanilla line). The intracellular Ca2+ concentration 
following the flash is shown in the upper trace. (A′) The Munc13-2 KO trace was normalized to the WT 
amplitude at 4 s after the flash. (B-C) Comparison of the exocytotic burst (P=0.096) and sustained release 
(P=0.080) in WT control and Munc13-2 KO cells. The exocytotic burst and sustained release were 
determined as the ∆Cm 1 s and 2 s to 5 s after the flash, respectively. (D-E) Kinetic analysis of the 
capacitance traces revealed that the two burst components, fast (P=0.13) and slow (P=0.95), are both 
reduced in amplitude, without any change in the time constant. Error bars indicate standard error of the 
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 Although the release deficit in Munc13-2 KO LDCV exocytosis was statistically not 
significant, our data indicate that in the regulation of LDCV exocytosis in mouse 





3.1.3 Reduced Exocytosis in Chromaffin Cells from Munc13-1/2DKO 
Mice  
 In this study, we found that both the exocytotic burst and the sustained phase 
component were reduced in chromaffin cells deficient for either Munc13-1 or Munc13-
2 (Figure 6A-E, 7A-E). Next, we investigated LDCV secretion in chromaffin cells 
lacking both Munc13-1 and -2. Munc13-1/2 DKO mice are completely paralyzed, die 
immediately after birth and neurotransmitter secretion from both GABAergic and 
glutamatergic hippocampal neurons is completely abolished in Munc13-1/2 DKO mice 
(Varoqueaux et al., 2002). Thus we expected that LDCV exocytosis (both the exocytotic 
burst and the sustained component) might be abolished in Munc13-1/2 deficient 
chromaffin cells. We analyzed adrenal chromaffin cells from E18 (Embryonic day 18) 
embryos that were obtained by caesarean section of pregnant females from Munc13-1 
heterozygous and Munc13-2 homozygous KO background matings. Munc13-2 KO 
chromaffin cells were used as controls and compared with Munc13-1/2 DKO 
chromaffin cells. Interestingly, we found that the adrenal glands from Munc13-1/2 DKO 
mice were about 50% smaller than those of Munc13-2 KOs, which were 
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Figure 8. Reduced exocytosis in chromaffin cells from Munc13-1/2 DKO mice. 
(A) Exocytosis in mouse chromaffin cells from Munc13-2 KO and Munc13-1/2 DKO mice after flash 
photolysis of caged Ca2+. Average ∆Cm in response to flash photolysis of NP-EGTA in Munc13-2 KO 
(12 cells from 3 mice) and Munc13-1/2 DKO (14 cells from 3 mice). The intracellular Ca2+ concentration 
following the flash is shown in the upper trace. (A′) The Munc13-1/2 DKO trace was normalized to the 
Munc13-2 KO amplitude at 4 s after the flash. (B-C) Comparison of the exocytotic burst (P=0.0014) and 
sustained release (P=0.024) in control and Munc13-1/2 DKO cells. The exocytotic burst and sustained 
release were determined as the ∆Cm 1 s and 2 s to 5 s after the flash, respectively. (D-E) Kinetic analysis 
of the capacitance traces revealed that the two burst components, fast (P=0.040) and slow (P=0.011), are 
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 To test whether secretion is completely abolished in Munc13-1/2 DKO cells, we 
stimulated the chromaffin cells obtained from Munc13-2 KO and Munc13-1/2 DKO 
littermates using flash photolysis of caged Ca2+. We found that in chromaffin cell from 
the Munc13-1/2 DKO mice, both the exocytotic burst (by ~40%, Figure 8B, Table 1) 
and the sustained component (by ~70%, Figure 8C, Table 1) were reduced significantly 
compared to Munc13-2 KO cells (Figure 8A). 
 However, in contrast to the complete shutdown of SV exocytosis from Munc13-1/2 
DKO hippocampal neurons (Varoqueaux et al., 2002), exocytosis from chromaffin 
cells, although drastically reduced, was not abolished entirely in the absence of both 
Munc13-1 and -2. 
 
 In order to investigate the release kinetics of exocytosis we fitted individual 
capacitance traces within the first 1 s after the flash with a sum of exponentials. We 
found that compared to chromaffin cells from Munc13-2 KO littermates, cells from 
Munc13-1/2 DKO mice showed a reduction of 40% in the fast and of 75% in the slow 
burst amplitude (Figure 8D-E, Table 1). Taking into account that, compared to WT, 
Munc13-2 KO cells already have a 30%-40% reduction of exocytosis, both the 
exocytotic burst and the sustained component were reduced more drastically in the 
Munc13-1/2 DKOs than in either single KO (Figure 20). Furthermore, like the loss of 
Munc13-1 or Munc13-2 alone, the absence of both isoforms had no effect on the 
vesicular release kinetics during the exocytotic burst (Figure 8D-E, Table 1), nor did 
normalization of the traces to the sustained component reveal a selective alteration of 
the kinetics of the sustained component (Figure 8A′). Taken together, these findings 
indicate that the presence of Munc13-1 suffices for the establishment of an almost WT-
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the releasable pool during ongoing release is severely impaired in the absence of both 
isoforms. As in the previous experiments, no effect on [Ca2+]i was detected in the 
absence of Munc13-1 and Munc13-2 (Figure 8A, top). Thus, both Munc13-1 and -2 are 






Figure 9. Rescue of exocytosis in Munc13-1/2DKO chromaffin cells by 
overexpression of Munc13-1 
(A) Average ∆Cm in response to flash photolysis of NP-EGTA in E18 Munc13-1/2 DKO cells 
overexpressing either EGFP (9 cells from 3 mice) or Munc13-1 (7 cells from 3 mice). The intracellular 
Ca2+ concentration following the flash is shown in the upper trace. (A′) The Munc13-1-SFV trace was 
normalized to the EGFP-SFV amplitude at 4 s after the flash. (B-C) Comparison of the exocytotic burst 
(P=0.019) and sustained release (P=0.0009) in cells overexpressing EGFP and cells overexpressing 
Munc13-1. The exocytotic burst and sustained release were determined as the ∆Cm 1 s and 2 s to 5 s after 
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 To confirm these results, we tested whether Munc13-1-SFV overexpression in 
Munc13-1/2 DKO chromaffin cells would rescue secretion. Using the SFV expression 
system, we infected mouse chromaffin cells obtained from Munc13-1/2 DKO mice with 
the RNA coding for Munc13-1 tagged with EGFP (Enhanced Green Fluorescent 
Protein) (Ashery et al., 1999). The average capacitance after flash photolysis of caged 
Ca2+ was larger in Munc13-1 overexpressing cells than in EGFP overexpressing cells 
(Figure 9A). Both the exocytotic burst (Figure 9B, 633.72 ± 121.3 fF, P=0.019) and the 
sustained component (Figure 9C, 372.57 ± 88.56 fF, P=0.0009) were increased 
significantly. Normalization of the Munc13-1-SFV trace to the trace of EGFP-SFV 
control cells revealed no significant changes in the kinetics of the sustained component 
(Figure 9A′). Thus, in agreement with previous studies that showed that overexpression 
of Munc13-1 in WT chromaffin cells boosted LDCV release (Ashery et al., 2000), 
overexpression of Munc13-1 in Munc13-1/2 DKO chromaffin cells leads to both a 




3.1.4 Exocytosis in Chromaffin Cells from Munc13-3 KO and Munc13-
1/2/3 TKO Mice  
 In addition to Munc13-1 and -2, a third Munc13 isoform, Munc13-3, is also expressed 
in bovine chromaffin cells (Ashery et al., 2000) and mouse adrenal gland (Figure 17A). 
To test whether Munc13-3 also contributes to the regulation of LDCV exocytosis, we 
stimulated chromaffin cells obtained from P0 WT and Munc13-3 KO littermate mice 
using flash photolysis of caged Ca2+.  
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Figure 10. Exocytosis in chromaffin cells from Munc13-3KO and Munc13-1/2/3 
Triple knockout (TKO) mice. 
(A) Average ∆Cm in response to flash photolysis of NP-EGTA in chromaffin cells cultured at P0 from 
WT (15 cells from 3 mice, black line) and Munc13-3 KO mice (12 cells from 3 mice, magenta line). The 
intracellular Ca2+ concentration following the flash is shown in the upper trace. (A′) The Munc13-3 KO 
trace was normalized to the WT amplitude at 4 s after the flash. (B-C) Comparison of the exocytotic burst 
and sustained release in WT control and Munc13-3 KO cells. The exocytotic burst and sustained release 
were determined as the ∆Cm 1 s and 2 s to 5 s after the flash, respectively. (D) Average ∆Cm in response 
to flash photolysis of NP-EGTA in chromaffin cells cultured at E18 from Munc13-2/3 DKO (17 cells 
from 3 mice, blue line) and Munc13-1/2/3 TKO mice (13 cells from 3 mice, purple-red line). The 
intracellular Ca2+ concentration following the flash is shown in the upper trace. (D′) The Munc13-1/2/3 
TKO trace was normalized to Munc13-2/3 DKO amplitude at 4 s after the flash.  (E-F) Comparison of the 
exocytotic burst and sustained release in Munc13-2/3 DKO and Munc13-1/2/3 TKO cells. The exocytotic 
burst and sustained release were determined as the ∆Cm 1 s and 2 s to 5 s after the flash, respectively. 
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 We found that the exocytotic burst and the sustained component were not reduced 
compared to WT, nor were the release kinetics altered (Figure 10A-C, Table 1), most 
likely because Munc13-1 and Munc13-2 are able to compensate for the absence of 
Munc13-3. The postflash [Ca2+]i did not differ between WT and Munc13-3 KO cells 
(Figure 10A, top). 
 Lastly, to investigate whether the secretion is completely abolished in cells lacking all 
three Munc13 isoforms (Munc13-1, -2, and -3), we obtained chromaffin cells from 
Munc13-1 heterozygous and Munc13-2/3 double homozygous KO background matings. 
Munc13-1/2/3 TKOs are completely paralyzed, die immediately after birth and look 
rather similar to Munc13-1/2 DKO mice (Varoqueaux et al., 2002). For the Munc13-
1/2/3 TKO experiments control chromaffin cells were cultured from Munc13-2/3 DKO 
littermates, which were viable and fertile. We analyzed adrenal chromaffin cells from 
E18 embryos that were obtained by caesarean section of pregnant females. Compared to 
Munc13-2/3 double deficient cells, Munc13-1/2/3 triple deficient chromaffin cells 
showed no significant changes in the exocytotic burst, the sustained component, or in 
the kinetics of release (Figure 10D-F, Table 1, Figure 10A′). 
 Based on our data, the sustained component in both the Munc13-2/3 DKO and 
Munc13-1/2/3 TKO cells was reduced by at least 50 % (Figure 20, Figure 10F). Since it 
is not possible to obtain WT and Munc13-1/2/3 triple deficient mice in the same litter at 
a frequency that is experimentally feasible, we were unable to accurately assess the 
contribution of Munc13-3 to LDCV exocytosis. However, taken together, the our data 
imply that the absence of Munc13-3 seemed to have the smallest effect on LDCV 
exocytosis, and furthermore, that residual LDCV exocytosis persists in the absence of 
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3.1.5 Enhanced Exocytosis in Chromaffin Cells from Baiap3 KO Mice  
 We first investigated basic properties of exocytosis in mouse adrenal chromaffin cells 
obtained from P0 Baiap3 KO and WT littermates.  
 
 
Figure 11. Increased exocytosis in chromaffin cells from Baiap3 deficient mice. 
(A) Average ∆Cm in response to flash photolysis of NP-EGTA in WT control (27 cells from 6 mice) and 
Baiap3 KO (28 cells from 6 mice). The intracellular Ca2+ concentration following the flash is shown in 
the upper trace. (A′) The Baiap3 KO trace was normalized to WT amplitude at 4 s after the flash. (B-C) 
Comparison of the exocytosis burst and sustained release (P=0.031) in control and Baiap3 KO cells. The 
exocytotic burst and sustained release were determined as the ∆Cm 1 s and 2 s to 5 s after the flash, 
respectively. (D-E) Kinetic analysis of the capacitance traces revealed that the two burst components, fast 
and slow components, are unchanged. Error bars indicate standard error of the mean. *, P < 0.05; **, P < 





    67 
 To test whether LDCV exocytosis is regulated by Baiap3, we stimulated chromaffin 
cells obtained from Baiap3 KO mice by flash photolysis of caged Ca2+. We found that 
the sustained component of release was significantly increased by 30% in Baiap3 
deficient cells (P=0.031, Figure 11C), whereas the exocytotic burst was unchanged 
(Figure 11B,D-E). However, normalization of the traces to the sustained component 
revealed no significant differences in the kinetics of the sustained phase (Figure 11A′), 
which argues against an effect that is specific to the sustained phase. Postflash [Ca2+]i 
values were similar in WT and KO cells, indicating that the increase in sustained 
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3.1.6 Depolarization Induced LDCV Exocytosis in Chromaffin Cells from 
Munc13-1/2 DKO and Baiap3 KO Mice 
 We have shown that LDCV exocytosis induced by uncaging Ca2+ in Munc13-1/2 DKO 
cells was drastically reduced in both the exocytotic burst and the sustained component 
of release. To investigate the effect of Munc13-1 and -2 deletion on LDCV exocytosis 
in response to a more physiological stimulus, chromaffin cells were stimulated with a 
voltage protocol consisting of six 10 ms depolarizations followed by four 100 ms 
depolarizations (Figure 12A top). The 10 ms depolarizations cause the fusion of the 
IRP, which corresponds to the fraction of the readily releasable vesicles that are closely 
associated with Ca2+ channels. The subsequent 100ms depolarizations elicit fusion of 
the remainder of the readily releasable pool (RRP), and the IRP and RRP together 
correspond to the fast component of flash photolysis experiments (Voets et al., 1999). 
Munc13-2 KO chromaffin cells responded the train of depolarizing stimuli with robust 
increases in membrane capacitance. In contrast to this, the secretory response was 
drastically reduced in chromaffin cells from Munc13-1/2 DKO cells. In chromaffin cells 
deficient for Munc13-1, and -2, exocytosis in response depolarization was significantly 
reduced. Both the IRP (Figure 12B, 7.7 ± 2 fF, P=0.0009) and the RRP (Figure 12C, 
55.9 ± 7 fF, P=0.0005) in Munc13-1/2 DKO cells were reduced compared to Munc13-2 
KO cells (Figure 12B, IRP: 33.8 ± 7 fF; Figure 12C, RRP: 108.7 ± 11 fF). Measurement 
of Ca2+ currents did not reveal significant differences between the Munc13-1/2 DKO 
and Munc13-2 KO chromaffin cells (Figure 12D). The reduction in both the IRP and the 
RRP is consistent with the reduction in the fast component seen in flash photolysis 
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Figure 12. Depolarization induced exocytosis in chromaffin cells from Munc13-1/2 
DKO and Baiap3 KO mice. 
(A) Voltage protocol (top) and the resulting average capacitance increase in E18 chromaffin cells from 
Munc13-2 KO (15 cells from 3 mice, black line) and Munc13-1/2 DKO mice (17 cells from 3 mice, red 
line). Chromaffin cells were stimulated with trains of short depolarizations, and the Ca2+ current and 
membrane capacitance were monitored simultaneously before and after stimulation. (B) IRP (P=0.0009), 
determined as the average capacitance during the time period indicated by the left dashed rectangle in A. 
(C) RRP (P=0.0005), determined as the average capacitance during the time period indicated by the right 
dashed rectangle in A. (D) The average Ca2+ current was identical in the Munc13-2 KO and Munc13-1/2 
DKO cells shown in A. (E) Voltage protocol (top) and resulting average capacitance increase in P0 
chromaffin cells from WT (20 cells from 4 mice, Black line) and Baiap3 KO (32 cells from 4 mice, lime 
line) mice. Chromaffin cells were stimulated with trains of short depolarizations, and the Ca2+ current and 
membrane capacitance were monitored simultaneously before and after stimulation. (F) IRP, determined 
as the average capacitance during the time period indicated by the left dashed rectangle in E. (G) RRP, 
determined as the average capacitance during the time period indicated by the right dashed rectangle in E. 
(H) The average Ca2+ current was identical in the WT and Baiap3 KO cells shown in A. Error bars 
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 Since there was no selective reduction of the IRP, Munc13-1 and -2 do not appear to 
control the docking and priming of vesicles near Ca2+, and our data consistently point to 
a general role for Munc13-1 and -2 in the docking/priming of vesicles in all release 
pools. 
 We also analyzed the response of Baiap3 KO cells to the depolarization protocol 
(Figure 12E top). Consistent with the previous finding that after flash photolysis the 
sustained component, but not the exocytotic burst was increased in Baiap3 KO cells 
(Figure 11), the voltage protocol consisting of six 10 ms depolarizations followed by 
four 100 ms depolarizations did not reveal any significant differences in the IRP (Figure 
12F, 62.4 ± 7 fF) and RRP (Figure 12G, 167.9 ± 14 fF) of Baiap3 KO cells compared to 
WT cells (IRP; 55.6 ± 7 fF, RRP; 164.5 ± 14 fF). The Ca2+ currents of Baiap3 KO cells 




3.1.7 Reduced Exocytosis in Chromaffin Cells Overexpressing Baiap3 
 To confirm the finding that loss of Baiap3 leads to an increase in the sustained 
component of release, we examined whether the opposite situation, overexpression of 
Baiap3, would reduce the LDCV exocytosis. We overexpressed either EGFP or Baiap3 
as an IRES (internal ribosome entry site)-EGFP construct with SFV in WT chromaffin 
cells. Expression of Baiap3 from the viral construct was confirmed by Western blot 
analysis of Baiap3-SFV infected BHK cells (Figure 13A). Complementary to the 
increase in exocytosis seen in the absence of Baiap3 (Figure 11), overexpression of 
Baiap3 resulted in a smaller capacitance change after flash photolysis of caged Ca2+ than 
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Figure 13. Reduced exocytosis in chromaffin cells overexpressing Baiap3.  
(A) Overexpression of Baiap3-SFV in BHK cells. (B) Average ∆Cm in response to flash photolysis of 
NP-EGTA in P0 EGFP overexpressing WT cells (23 cells from 5 mice) and Baiap3 overexpressing WT 
cells (24 cells from 5 mice). The intracellular Ca2+ concentration following the flash is shown in the upper 
trace. (B′) The Baiap3 KO trace was normalized to the WT amplitude at 4 s after the flash. (C-D) 
Comparison of the exocytotic burst (P=0.008) and sustained release (P=0.0004) in cells overexpressing 
EGFP and cells overexpressing Baiap3. The exocytotic burst and sustained release were determined as 
the ∆Cm 1 s and 2 s to 5 s after the flash, respectively. (E-F) Kinetic analysis of the capacitance traces 
revealed that the two burst components, fast (P=0.014) and slow (P=0.025), are both changed. Error bars 
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 Overexpression of Baiap3 significantly depressed both the exocytotic burst (Figure 
13C, 293.3 ± 34.17 fF, P=0.008) and the sustained component (Figure 13D, 51.1 ± 12.8 
fF, P=0.0004) in comparison to EGFP overexpressing cells (Figure 13C-D, 500.23 ± 51 
fF (Burst), 165.1 ± 27.2 fF (Sustained)). We found that in the exocytotic burst of Baiap3 
overexpressing cells both the fast (Figure 13E, 109.2 ± 12.1 fF, P=0.014) and the slow 
burst (Figure 13F, 209 ± 34 fF, P=0.025) were significantly smaller than in EGFP 
overexpressing cells (Figure 13E-F, 143.4 ± 16 fF (fast), 463.1 ± 40 fF (slow)).  
 The overpexpression of Baiap3 thus has the opposite effect of overexpressing Munc13-
1 (Figure 9). However, like Munc13-1, Baiap3 does not appear to affect the kinetics of 
the exocytotic burst (Figure 13E-F) or the kinetics of the sustained component (Figure 
13B′). Postflash [Ca2+]i was also closely matched between EGFP- and Baiap3 
overexpressing cells (Figure 13B, top).  
 In summary, our data indicate that Baiap3 reduces the number of fusion-competent 
vesicles and inhibits vesicle recruitment and priming during ongoing release while Ca2+ 
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3.2 Functional Characterizations of Baiap3  
 
 
3.2.1 Basic Characterization of Baiap3 KO Mice 
 Baiap3 deficient mice were generated by homologous recombination in mouse 
embryonic stem cell (Figure 14A). Targeting vector construction and gene targeting in 
ES cells was done by Dr. Iris Augustin. 
 
 
Figure 14. Gene targeting strategy to generate Baiap3 KO mice. 
(A) Targeting vector and Baiap3 locus before and after homologous recombination. (B) Genomic 
Southern blot with an external 5′ probe after BamHI digestion of stem cell DNA. Homologous 
recombination of the Baiap3 targeting vector results in a shift of a WT 5.5 kb BamHI fragment to 4.2 kb. 
(C) Genomic PCR used for genotyping Baiap3 litters with 546 bp for WT and 636 bp for the KO. (D) 
Northern blot analysis with a 3′ probe that lies outside the deleted region shows that Baiap3 mRNA is not 
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Figure 15. Specificity of Baiap3 antisera. 
Specificity of Baiap3 antisera in mouse whole brain from WT and Baiap3 KO mice. SA5990 and SA5991 
were generated in rabbit against the MHD to C-terminal region of Baiap3. The antibody against the N-
terminus (Dr. Iris Augustin) was also generated in rabbit. All of antisera recognize Baiap3 in WT mice. 
 
 
 Baiap3 KO mice were obtained at the predicted Mendelian frequency. The respective 
genotypes were initially detected by Southern blotting (Figure 14B), by PCR for routine 
genotyping (Figure 14C), and by Northern blotting to check for mRNA expression 
(Figure 14D). Baiap3 KO mice are viable and fertile and show no obvious phenotypic 
changes in the cage environment. Litter sizes resulting from interbreeding of 
homozygous Baiap3 deficient animals were indistinguishable from those obtained with 
WT controls. 
 To verify Baiap3 protein expression level in WT and Baiap3 KO mice, we generated 
three polyclonal anti-Baiap3 antisera, which were raised to either the N-terminus or a 
region of Baiap3 encompassing the MHDs and C-terminus (Figure 15). Western blot 
analysis of homogenates from whole brain and other tissues showed that Baiap3 protein 
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Figure 16. Protein Expression of Baiap3. 
(A) Expression of Baiap3 in sub-regions of the brain and (B) brain, lung and adrenal gland. Baiap3 is not 
expressed in the pancreas and, in contrast to Munc13-4, is absent from spleen. Tissues were 
homogenized, and the proteins were separated by SDS-PAGE and analyzed by immunoblotting with 
antibodies to the indicated proteins. (C) Panels on the left show the distribution of Baiap3 in subcellular 
fractions of brain homogenate. Fractions (10 µg protein per lane) were analyzed by SDS-PAGE and 
immunoblotting with antibodies to the indicated proteins. Hom, Homogenate; P1, nuclear pellet; P2, 
crude synaptosomal pellet; P3, light membrane pellet; LP1, lyzed synaptosomal membranes; LP2, crude 
synaptic vesicle fraction; SPM, synaptic plasma membranes; S1, supernatant after synaptosome 
sedimentation; S3, cytosolic fraction; LS1, supernatant after LP1 sedimentation; LS2, cytosolic 
synaptosomal fraction. Panels on the right show the expression of Baiap3 during development from E18 
to P90 (Dr. Iris Augustin). Immunoblotting was done with antibodies to the indicated proteins.  
 
 
 The absence of Baiap3 expression did not affect the protein levels of any of the 
proteins involved in vesicle exocytosis that we investigated (Figure 17A). These 
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core complex components (Syntaxin, SNAP-25, and Synaptobrevin), and the SNARE 
regulatory protein Munc18 (Figure 17A). In order to determine where in the brain 
Baiap3 is expressed, we performed Western blot analysis on sub-regions of the brain. 
Baiap3 expression is most prominent in the hypothalamus, thalamus, colliculi, septum 
and in the brain stem. Unlike Munc13-1 and Munc13-2, Baiap3 is not strongly 
expressed in hippocampus (Figure 16A). To study developmental regulation and 
subcellular distribution of Baiap3 protein in WT mice, we analyzed the expression level 
by Western blotting. The expression level of Baiap3 was very low at E18 and increased 
during postnatal development to reach a plateau at P12-P18 (Figure 16C). In the 
subcellular fractionation, Baiap3 was enriched in the crude synaptic vesicle fraction 
(LP2). However, unlike Munc13-1 and NMDA R1 (the postsynaptic density component 
marker), Baiap3 is not enriched in synaptic plasma membrane (SPM) (Figure 16C). 
 Among the Munc13 family members, Munc13-4 is the isoform most closely related to 
Baiap3 (Koch et al., 2000). However, unlike the other Munc13s and Baiap3, Munc13-4 
is not expressed in neurons. Like Munc13-4, Baiap3 is also expressed in lung and 
adrenal gland (Figure 16B). Furthermore, we found that Munc13-1, -2, -3 and Baiap3 
are expressed in mouse adrenal gland (Figure 17A). We did not detect any alterations in 
the expression levels of Munc13 isoforms and SNARE core complex components in 
Baiap3 deficient adrenal glands. The expression level of Chromogranin A, an LDCV 
marker, was also not changed (Figure 17A). Baiap3 was initially identified as a binding 
partner BAI1 in a yeast two-hybrid screen (Shiratsuchi et al., 1998). The significance of 
this interaction has not been determined and we found no alteration of the BAI1 protein 
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Figure 17. Immunoblot analysis of adult whole brain and adrenal gland. 
(A) Expression of SNARE complex components and SNARE regulatory proteins in whole brain and  
adrenal gland from WT and Baiap3 KO mice. (B) Expression of Baiap3 protein in whole brain of 
Munc13 DKO and WT mice. Whole brain and adrenal glands from mice were homogenized, and protein 
(10 µg for brain, and 20 µg for adrenal gland per lane) was analyzed by SDS-PAGE and immunoblotting 
with antibodies to the indicated proteins. 
  
 
 We also checked whether Baiap3 expression might be altered in the absence of 
Munc13-1 and -2, but found not differences of Baiap3 protein levels between WT and 
Munc13-1/2 DKO brains (Figure 17B). While Baiap3 shows a more restricted 
expression level in the brain than Munc13-1 and Munc13-2, Baiap3 and Munc13-1, -2, 
and -3 are coexpressed in mouse adrenal gland, and, based on the electrophysiological 
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3.2.2 Baiap3 Binds to Both Munc13-1 and Syntaxin 1 
 Munc13s are essential regulators of SNARE-mediated exocytosis of SVs. Munc13-1 
binds not only Syntaxin 1 but also other SNARE core components (Betz et al., 1997). In 
order to determine whether Baiap3 also bound to SNARE core complex components we 
performed co-sedimentation assays by using recombinant GST fusion protein 
constructs. GST-Syntaxin-1A was able to bind not only Munc13-1, but also bound 
Baiap3 in co-sedimentation assays performed with recombinant Munc13-1 or Baiap3 




Figure 18. Baiap3 binds to Syntaxin and the MHDs of Munc13-1. 
(A) Representative co-sedimentation assays of GST-fused-Syntaxin 1A (a.a.1-276) and of GST alone 
with Baiap3 or Munc13-1 produced in HEK293FT cells. Munc13-1 was used as a positive control for 
Syntaxin binding and HEK 293FT cells were transfected with either MYC-Baiap3 or EGFP-Munc13-1. 
(B) Representative co-sedimentation assays of several GST-fused Mun13-1 fragments and of GST alone 
with Baiap3 produced in HEK293FT cells. (C) Domain structure of Munc13-1 and representation of 
GST-Munc13-1 fusion constructs; pGEX-Munc13-1-176/178 (a.a 517-1735), pGEX-Munc13-1-N1/N2 
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Figure 19. Binding of SNARE complex core components and Munc13-1 to a 
recombinant Baiap3 fragment encompassing the MHDs. 
GST-Baiap3-MHDs-fusion protein and GST alone as a control were used for cosedimentation assays. 




 To determine whether Baiap3 also interacts with Munc13-1, we used recombinant 
protein fragments of Munc13-1. Recombinant GST-Munc13-1 fusion fragments (Betz 
et al., 1997; Figure 18C) were used in co-sedimentation assays with cell lysate from 
HEK293FT cells expressing Baiap3, and bound material was assayed for by 
immunoblotting. Two Munc13-1 constructs, pGEX-Munc13-1-176/178 (a.a 517-1735) 
and pGEX-Munc13-1-13'1 (a.a 1032-1345), were capable of binding to Baiap3 (Figure 
18B). The overlapping regions of the two constructs contain the MHDs of Munc13-1, a 
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 To test whether Baiap3 is also able to bind Syntaxin and Munc13-1 in a more native 
context, we used a GST-Baiap3-MHDs fusion protein in a co-sedimentation assay with 
mouse whole brain homogenate. The GST-Baiap3-MHDs construct pulled down not 
only Munc13-1 but also SNARE core complex components (Syntaxin 1A/B, SNAP-25 
and Synaptobrevin 2) (Figure 19). 
 
 These data indicate that Baiap3 interacts with Syntaxin 1 and Munc13-1, and may be 
associated with the SNARE core complex by binding to Syntaxin 1 and/or Munc13-1. 
In these experiments, we attempted to use recombinant soluble Baiap3. However, 
Baiap3 fragments containing the MHD domains are highly insoluble when expressed in 
E. coli, and Baiap3 expressed in HEK293FT cells was mostly recovered in the detergent 
insoluble membrane fraction and we could not obtained a soluble sample of Baiap3. We 
do not know whether the detergent insolubility of Baiap3 overexpressed in cells was 








 This is the first study to systematically investigate the role of the Munc13 protein 
family in LDCV exocytosis. We found that Munc13-1, Munc13-2, which were known 
to be essential positive regulators of SNARE-mediated exocytosis of neuronal SVs, also 
control LDCV exocytosis in chromaffin cells. Remarkably, one member of this protein 
family, Baiap3, seems to suppress LDCV exocytosis in chromaffin cells, making 
Baiap3 the first Munc13 homologue for which a negative regulatory function in 
exocytosis has been described. 
 
 
4.1 Munc13s are Positive Regulators of LDCV Exocytosis 
 Munc13s are essential for the exocytosis of neuronal SVs in invertebrates as well as in 
mammals (Augustin et al., 1999b; Varoqueaux et al., 2002; Richmond et al., 1999; 
Aravamudan et al., 1999). However, their physiological role in mammalian LDCV 
exocytosis had previously only been examined by overexpression of either Munc13-1 or 
Munc13-2 in WT chromaffin cells (Ashery et al., 2000; Stevens et al., 2005; Zikich et 
al., 2008). The three Munc13 isoforms whose role in neuronal SV exocytosis has been 
established, Munc13-1, -2 and -3, are also found in bovine chromaffin cells (Ashery et 
al., 2000; Zikich et al., 2008) and in mouse adrenal gland (Figure 17). To examine the 
role of endogenous Munc13s in Ca2+ triggered LDCV exocytosis, we studied exocytosis 
in chromaffin cells taken from Munc13-1, -2, -3 and Baiap 3 deficient mice, using flash 
photolysis of caged Ca2+. Flash photolysis protocols cause a sudden uniform increase in 
the concentration of intracellular Ca2+ throughout the cell, triggering an exocytotic burst 





burst component consists of those vesicles that were already in a fusion competent, i.e. 
docked and primed state, at the time of the stimulus, whereas the sustained component 
consists of vesicles that undergo Ca2+-dependent docking, priming and release while 
Ca2+ levels remain high (Neher, 2006). However, the pool of vesicles released in the 
burst phase and those released during the sustained phase are a continuous pool of 
vesicles in the sense that they need to go through the same maturations steps, i.e. 
docking and priming prior to release. 
 
 Among the four mouse lines studied, the most drastic reduction of release seen in the 
absence of a single Munc13 isoform, was detected in the Munc13-1 deficient 
chromaffin cells. Without Munc13-1, the secretory burst was reduced by 40% and the 
sustained component by 50% (Figure 6, Figure 20). In Munc13-2 deficient chromaffin 
cells, the reduction of the burst phase and the sustained phase was only 30% and 40%, 
respectively, which was statistically not significant (Figure 7, Figure 20). However, in 
chromaffin cells lacking both Munc13-1 and -2, the reduction in burst and sustained 
release was greater than in both single knockouts, indicating that Munc13-2 also 
functions to regulate LDCV exocytosis (Figure 8, Figure 20). The absence of Munc13-3 
on the other hand, had no significant effect on either the burst or sustained phase of 
release (Figure 10, Figure 20). In addition to the distinction between the burst phase of 
release and the sustained phase, analysis of the kinetics of release during the burst phase 
reveals the presence of a slow and a fast burst components, which is thought to 
represent different states of the fusion machinery that translate into differences in the 
“readiness” of docked and primed vesicles to fuse (Neher, 2006). The state of the fusion 
machinery that is responsible for the slow burst seems to be a precursor of the 
configuration that mediates the fast burst (Voets et al. 1999). Since Munc13s are 





the fast and the slow burst components, as is the case for most manipulations of the size 
of the burst pool (Neher 2006). In line with this assumption, in Munc13-1 and Munc13-
1/2 DKO cells, i.e. those genotypes with a significant reduction in the exocytotic burst, 
both the slow and the fast burst component were reduced, without any significant 
change in the time constants (Figure 6D,E and Figure 8D,E).  
 
 Our study is the first report of a deficit in LDCV exocytosis from chromaffin cells in 
Munc13 deficient animals, and establishes that endogenous Munc13-1 and Munc13-2 
regulate LDCV exocytosis in chromaffin cells. Since both the burst and the sustained 
component of release were reduced, without any change in their kinetics (Figures 6-8) 
our data are best explained by a model in which Munc13-1 and -2, in principle, have 
equivalent roles as docking/priming factors in establishing the pool of release ready 
vesicles (vesicles released during the burst phase) and in the Ca2+-dependent 
docking/priming of new LDCVs during the sustained phase of release. Munc13-1 may 
be more efficient in mediating the docking/priming process, its absence thus having the 
greatest effect. However, the apparent differences in priming efficiency between 
Munc13-1, -2 and -3 could of course also be due to differences in the level of protein 
present in chromaffin cells. Unfortunately, we were not able to compare proteins levels 
directly, because the amount of protein that could be obtained from cultured chromaffin 
cells was too low, and whole adrenal glands also contain synapses, presumably with 
unknown amounts of different Munc13 isoforms. Somewhat surprisingly, while deletion 
of Munc13-1 and -2 completely eliminates SV exocytosis in cultured hippocampal 
neurons (Augustin et al., 1999b; Varoqueaux et al., 2002), LDCV exocytosis was not 
completely abolished even in the absence of Munc13-1 -2 and -3 (Figure 10D-F). 
Munc13-independent neurotransmitter release has however been described for the 





priming of LDCVs therefore appears to involve other regulatory proteins, whose 
identity and function of remains to be investigated. Potentially Caps proteins, which are 
involved in SVs exocytosis in mammalian neurons (Jockusch et al., 2007) as well in 
LDCV exocytosis in chromaffin cells (Elhamadani et al., 1999; Liu et al., 2008) and in 
C. elegans (Speese et al., 2007, Zhou et al., 2007) could be responsible for the residual 
LDCV release in the absence of Munc13s. Yet, Caps and Munc13 do not perform the 
same function in the docking/priming reaction, since overexpression of one does not 
rescue the phenotype seen in the absence of the other (Jockusch et al., 2007), which 
argues against this theory. Two other obvious candidates that might be responsible for 
LDCV exocytosis in the Munc13-1, -2, -3 TKOs, would be the two remaining members 
of the Munc13 protein family, Munc13-4 and Baiap3. However, we were unable to 
detect Munc13-4 in adrenal gland by Western blotting (data not shown), and based on 
our analysis of the role of Baiap3 in chromaffin cells, Baiap3 is a negative rather than a 
positive regulator of LDCV exocytosis. 
 
Figure 20. Relative amplitude sizes of the burst and sustained phases of LDCV 






4.2 Baiap3/Bap3 is a Negative Regulator of LDCV Exocytosis.     
  
 Baiap3 was first identified and named as a binding partner of the brain specific 
angiogenesis inhibitor I (BAI1), which encodes a seven span transmembrane protein, 
which belongs to the adhesion-type G-protein-coupled receptor family (Shiratsuchi et 
al., 1998). Evolutionarily, Baiap3 appears the be related to Munc13s, its domain 
structure is homologous to the Munc13 C-terminal half which features two Munc-
homology-domains (MHDs) flanked by C2 domains (Shiratsuchi et al., 1998; Koch et 
al., 2000). Based on sequence similarity, the closest relative of Baiap3 is the non-
neuronal isoform Munc13-4 (Figure 21; Table 2; Koch et al., 2000), which is essential 
for exocytosis of secretory granules from cells of the hematopoietic lineage (Feldmann 
et al., 2003; Neeft et al., 2005). 
  
 Because all Munc13 isoform whose function had been analyzed previously were found 
to be positive regulators of SNARE-mediated exocytosis, we were surprised to discover 
that LDCV exocytosis was in fact enhanced, rather than reduced in the absence of 
Baiap3 (Figure 11). Conversely, when we overexpressed Baiap3 in WT chromaffin 
cells, LDCV exocytosis was dampened, indicating that Baiap3 negatively regulates 
LDCV exocytosis (Figure 13). In flash photolysis experiments using Baiap3 KO 
chromaffin cells, only the sustained component was increased, whereas overexpression 
suppressed both the burst and the sustained component of release. This suggests that 
Baiap3 suppresses both the pre-burst docking/priming of vesicles and the recruitment of 










Figure 21. Protein Sequence Comparison of the C2 domains and the MHDs of 





          
 
Table 2. Percent identity of the domain structure of Munc13s and Baiap3. 
 
 
 To further analyze the effect of Munc13-1/2 and Baiap3 on the release-ready vesicle 
pool, we also stimulated Munc13-1/2 DKO and Baiap3 KO cells by depolarization. 
Depolarization protocols do not lead to the sudden uniform increase in the intracellular 
Ca2+ concentration achieved by flash photolysis, because the Ca2+ enters the cell via 
voltage gated Ca2+ channels, allowing the experimental distinction between vesicles 
docked in the vicinity of Ca2+ channels and those docked at a greater distance based on 
their release kinetics (Schneggenburger and Neher, 2005). The immediately releasable 
pool (IRP) seen with depolarization is thought to represent those vesicles 
docked/primed closest to the Ca2+ channels, they are also released during the fast burst 
in flash photolysis experiments, but due to the uniform increase in intracellular Ca2+ do 
not show up as a separate pool (Voets et al., 1999). According to the model of LDCV 
exocytosis refined by Voets and colleagues (1999), the relationship between the vesicle 
pools mobilized by depolarization and by those release after flash photolysis is as 
follows: The IRP and the readily releasable pool (RRP) of vesicles released by 





(Figure 22), whereas the vesicles of the slow burst component and those of the sustained 
component are not released in response to our depolarization protocol.  
 
 Baiap3 KO cells, which showed no reduction in the fast or slow burst component after 
flash photolysis, also showed no deficit in the IRP or RRP released in response to 
depolarization (Figure 12E-H). Munc13-1/2 deficient cells on the other hand, which did 
have a deficit in the slow and the fast burst phase in responses to flash photolysis, also 
showed a deficit in the IRP and RRP exocytosis elicited by depolarization (Figure 12A-
D). Thus, neither Baiap3 nor Munc13-1 and Munc13-2 appear to be essential for 
selective docking/priming of vesicles in close vicinity of Ca2+ channels.  
 
 Taken together, our analyses of Munc13 and Baiap3 deficient chromaffin cells suggest 
that Baiap3 functions as a negative regulator of the same steps in LDCV exocytosis that 
are facilitated by Munc13-1 and Munc13-2. The fact that the exocytotic burst was not 
affected in Baiap3 KO cells, but suppressed when Baiap3 was overexpressed, can be 
explained if endogenous Baiap3 levels are not high enough to interfere with the 
establishment, i.e. docking and priming, of a WT-sized pool of vesicles when the cell 
has not been stimulated, but sufficiently high to impair the recruitment of new vesicles 
at times of high demand, i.e. during ongoing release. We therefore propose a model in 
which Baiap3 acts as an antagonist in the docking/priming reaction that requires 
Munc13-1 and Munc13-2 and is necessary to establish the release ready pool of vesicles 







Figure 22. Munc13s and Baiap3 control LDCV exocytosis. Munc13s are positive 
regulators and Baiap3 a negative regulator in recruiting LDCVs for release and 




4.3 Munc13s and Baiap3 as Regulators of SNARE-Mediated 
Exocytosis 
 The docking and priming reactions that occur before a vesicle reaches fusion 
competence require SNARE proteins and SNARE regulatory proteins like Munc13 and 
Munc18 (Augustin et al., 1999b; Jahn and Scheller, 2006; Varoqueaux et al., 2002; 
Verhage et al., 2000; Voets et al., 2001; Weimer et al., 2003). Munc13s are thought to 
facilitate SNARE complex formation by keeping Syntaxin in an open conformation 
(Betz et al., 1997; Brose et al., 2000; Richmond et al., 2001). Although SNARE 





docking step (Broadie et al., 1995; Hunt et al., 1994; Sørensen et al., 2003; Voets et al. 
2001; Washbourne et al., 2002), more recent evidence indicates that at least in C. 
elegans both Syntaxin and Unc-13 are required for vesicle docking. Docking defects in 
unc-13 mutant worms are rescued by the open form of Syntaxin, which indicates that 
SNARE complex formation may equal vesicle docking, with Unc-13 acting upstream of 
SNARE assembly (Hammerlund et al., 2007). In C.elegans, docking and exocytosis of 
SVs appears to require Unc-13 and Syntaxin, whereas docking and exocytosis of large 
dense core vesicles involves Caps and Syntaxin (Hammarlund et al., 2007; Hammarlund 
et al., 2008; Speese et al., 2007; Zhou et al., 2007), with Unc-13 playing a potential 
auxiliary role (Zhou et al., 2007; Hammarlund et al., 2008). By contrast, a clear division 
of labor between Munc-13 and Caps proteins in the regulation of SV and LDCV 
exocytosis does not appear to be a feature of the mammalian system. In mouse neurons, 
effective excitation-secretion coupling of SVs requires both Munc13 and Caps proteins 
(Jockusch et al. 2007), and our study shows that LDCV exocytosis, which has 
previously been shown to require Caps (Elhamadani et al., 1999; Liu et al., 2008), is 
also regulated by Munc13-1 and -2. Since physical docking of LDCVs in chromaffin 
cells also requires Syntaxin (de Wit et al., 2006), we propose that Munc13-1 and 
Munc13-2 regulate LDCV exocytosis by acting upstream of SNARE complex 
assembly, which does however not exclude the possibility that they have additional 
functions within the fusion machinery. 
 
 Our electrophysiological analysis of the role of Baiap3 in LDCV exocytosis suggests 
that Baiap3 acts as a negative regulator at the same step that requires Munc13-1 and -2. 
This notion is also supported by our biochemical data, which show that Baiap3 can bind 
to Syntaxin1 as well as to Munc13-1. It is therefore conceivable that Baiap3 and other 





components. Although we were unable to show that Baiap3 interferes with the binding 
of Munc13-1 to Syntaxin1, this may be an experimental limitation due to the fact that 
Munc13 does not interact with purified Syntaxin in solution (Basu et al., 2005) and the 
interaction therefore most likely requires additional factors. Because of the limited 
sequence similarity of Munc13-1 and Baiap3 (Table 2), they are unlikely to share all 
interaction partners, and binding of Baiap3 to Syntaxin may thus result in a 
configuration that is unfavorable to SNARE complex assembly 
 
 
 Other components of the fusion machinery for which a negative regulatory function in 
LDCV exocytosis has been reported are Amysin, Tomosyn (Yizhar et al., 2004; 
Constable et al., 2005) and Complexins (Archer et al., 2002; Itakura et al., 1999). 
Amysin and Tomosyn are a Syntaxin binding proteins with a C-terminal SNARE motif 
able form a fusion-incompetent SNARE complex with Syntaxin and SNAP-25 (Fujita et 
al., 1998; Scales et al., 2002; Pobbati et al., 2004; Groffen et al., 2005;). In C. elegans, 
Tomosyn antagonizes Unc-13-dependent release (Gracheva et al., 2006; McEwen et al., 
2006) and also negatively regulates CAPS-dependent peptide release from dense core 
vesicles (Gracheva et al., 2007). By comparison, the evidence that Complexins are 
negative regulators of exocytosis is weak, because although overexpression impairs 
exocytosis (Archer et al., 2002; Itakura et al., 1999), their deletion does the same (Reim 
et al., 2001), suggesting that their in vivo function is not an inhibitory one. In our case, 
the overexpression and deletion of Baiap3 resulted in compatible data sets, i.e. 
overexpression reduced LDCV exocytosis and deletion enhanced it. Since the effect of 
overexpression was greater than the effect of deletion, the efficacy of Baiap3 in 
interfering with Munc13-dependent docking/priming appears to be sensitive to the 





potentially sequester Syntaxin or Munc13, or both, thereby lowering the rate at which 
productive SNARE complexes are formed. However, the question remains, whether 
inhibition of LDCV exocytosis is the “true” function of Baiap3, or whether it is also a 
docking/priming factor, albeit a less efficient one. 
 
 To answer the open questions with respect to the mechanism of Baiap3 function it will 
also be necessary to determine its function in neurons. In the brain, Baiap3 has a more 
restricted expression pattern than Munc13-1 and Munc13-2, with prominent expression 
seen in hypothalamus, amygdala, periaqueductal grey, septum and several brainstem 
nuclei. We did not find obvious alterations in synaptic release of glutamate or GABA 
from cultured hypothalamic neurons, arguing against a function of Baiap3 in 
suppressing SV exocytosis. However, we were unable to reliably detect Baiap3 
expression by staining cultured neurons (data not shown), and it remains to be 
investigated whether those neurons that express Baiap3 in the intact brain survived in 
our cultures. Potentially, Baiap3 could also function as a regulator of LDCV exocytosis 
in neurons, and/or be involved in the vesicular release of neurotransmitters other than 





 I set out to determine whether mammalian LDCV exocytosis requires the same 
Munc13 isoforms that are essential for SV exocytosis, or whether the Munc13 relative 
Baiap3 might be more important for LDCV release. Two of the three neuronal Munc13 





chromaffin cells, and thus play a more significant role in LDCV exocytosis than their 
C.elegans counterpart Unc-13. I found that Baiap3 is also a regulator of LDCV 
exocytosis, but against all expectations, it functions to suppress LDCV exocytosis, 
making it the first member of the Munc13 protein family for which a negative 




4.5 Future Studies 
 Future experiments to further delineate the role of Munc13s and Baiap3 in mammalian 
LDCV exocytosis will include ultrastructural analysis of possible LDCV docking 
defects in Munc13-1/2 and Baiap3 deficient chromaffin cells by electron microscopy. 
Docking defects in the in Munc13 deficient neurons have not been described 
(Varoqueaux et al. 2002), however, it is possible that such docking defects were missed 
due to fixation artifacts (Hammerlund et al. 2008). In C.elegans, the Unc-13 docking 
deficit, as well as the functional release deficit was rescued if Tomosyn was deleted as 
well, implying that Unc-13 and Tomosyn are true functional antagonists (Gracheva et 
al., 2006; McEwen et al., 2006). Comparison of the number of docked vesicles in 
Munc13-1/2 KO and Baiap3 KO cells, combined with functional analysis of LDCV 
exocytosis in Munc13-1/2/Baiap3 triple deficient cells, may thus answer the question 
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 Members of mammalian uncoordinated 13 protein family (Munc13s) are essential for 
SV exocytosis in neurons and have also been implicated in LDCV exocytosis in 
chromaffin cells. However, the C.elegans ortholog Unc-13 appears to be dispensable for 
LDCV exocytosis, raising the question whether SNARE-mediated exocytosis of SVs 
and LDCVs is controlled by distinct regulatory proteins. We therefore analyzed LDCV 
exocytosis in cultured chromaffin cells taken from knockout mouse lines of four 
members of the Munc13 protein family, Munc13-1, Munc13-2, Munc13-3 and Baiap3. 
Baiap3/Bap3 (brain specific angiogenesis inhibitor 1 associated protein 3), was 
identified and named as an interaction partner of BAI 1 (brain specific angiogenesis 
inhibitor-1), and is a Munc13 homologue of unknown function. Its closet known 
relative, the non-neuronal Munc13-4, has been shown to be essential for the secretion of 
lymphocyte cytolytic granule content. Unlike Munc13-4, Baiap3 expression is largely 
restricted to brain and adrenal gland, with low levels also present in lung. To determine 
whether LDCV exocytosis is impaired in the absence of Munc13-1, Munc13-2, 
Munc13-3 or Baiap3, we combined flash photolysis of caged Ca2+ and membrane 
capacitance measurements in cultured chromaffin cells. Our analysis of exocytosis in 
chromaffin cells shows that Munc13-1 and Munc13-2 act as positive regulators of 
LDCV exocytosis and play a more critical role in the release of this vesicle type than 
their C.elegans ortholog Unc-13. Based on sequence similarity, Baiap3 is a member of 
the Munc13 protein family. However, unlike Munc13-1, -2, -3 and -4, which function as 
essential positive regulators of SNARE-mediated exocytosis, our data indicate that 
Baiap3 negatively regulators exocytosis, at least in chromaffin cells. In this study, we 
found that exocytosis in chromaffin cells from Munc13-1 deficient mice and mice 




exocytosis. In contrast to this, chromaffin cells deficient for Baiap3 showed increased 
exocytosis and Baiap3 overexpression in WT cells suppressed LDCV release. The exact 
molecular mechanism by which Munc13s regulate SNARE-mediated exocytosis 
remains to be elucidated. However, we found that Baiap3 interacted with both Munc13-
1 and Syntaxin in co-sedimentation assays, which indicates that competition for binding 
to SNARE complex components is a possible explanation for the opposing functions of 
Munc13-1/2 and Baiap3 LDCV exocytosis. 
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